JP7003033B2 - Woven structure with interlocked upright fibers - Google Patents

Description

The present disclosure relates to surgical instruments and, in various configurations, to surgical staples and cutting instruments designed to staple and cut tissue, and staple cartridges for use with them.

In the appended claims, the features of the various embodiments are described in detail. However, the various embodiments can be best understood by reference to the following description in conjunction with the accompanying drawings, along with their advantages, both in terms of their configuration and method of operation.
FIG. 3 shows a perspective view of a surgical staple fastening and cutting instrument with a handle, a shaft extending from the handle, and an end effector extending including anvils and staple cartridges. FIG. 1 is a perspective view of a wedge thread of a staple cartridge for a surgical stapler and a cutting instrument of FIG. FIG. 1 is a perspective view of a two-piece knife and firing bar (“E-beam”) of a surgical stapler and cutting instrument of FIG. FIG. 3 is a longitudinal cross-sectional view of an anvil in a closed position, a staple cartridge with a rigid support, and a compressible aid, showing a state in which the staples have moved from an unlaunched position to a fired position during the firing sequence. FIG. 4 is another cross-sectional view of the anvil and staple cartridge of FIG. 4, showing the anvil in the open position after the firing sequence is complete. FIG. 3 is a partial perspective view of a staple cartridge assembly with compressible aids according to at least one embodiment. FIG. 6 is a partial perspective view of the auxiliary material of FIG. 6 embedded in the tissue by at least one staple. FIG. 3 is a partial perspective view of an alternative compressible aid embedded in a tissue by at least one staple, according to at least one embodiment. FIG. 3 is a partial perspective view of a staple cartridge assembly with an alternative compressible aid according to at least one embodiment. FIG. 3 is a partial perspective view of a staple cartridge assembly with an alternative compressible aid according to at least one embodiment. FIG. 3 is a partial perspective view of an alternative compressible aid embedded in a tissue by at least one staple, according to at least one embodiment. FIG. 3 is a partial cross-sectional view of a staple cartridge assembly with an alternative compressible aid according to at least one embodiment. FIG. 3 is a partial cross-sectional view of a staple cartridge assembly with an alternative compressible aid according to at least one embodiment. FIG. 3 is a partial cross-sectional view of a staple cartridge assembly with an alternative compressible aid according to at least one embodiment. FIG. 3 is a partial perspective view of an alternative compressible aid according to at least one embodiment. FIG. 3 is a perspective view of the compressible auxiliary material of FIG. 13 arranged with respect to the cartridge deck of the staple cartridge. FIG. 3 is a perspective view of a staple cartridge assembly with an alternative compressible aid according to at least one embodiment. FIG. 3 is a partial perspective view of an alternative compressible aid according to at least one embodiment. FIG. 3 is a partial perspective view of a compressible auxiliary material according to at least one embodiment. It is sectional drawing of the compressible auxiliary material of FIG. It is a detailed view of the sectional view of FIG. FIG. 3 is a perspective view of a staple cartridge assembly with compressible aids according to at least one embodiment. FIG. 20 is another perspective view of the staple cartridge assembly of FIG. FIG. 20 is another perspective view of the staple cartridge assembly of FIG. FIG. 3 is a partial perspective view of a compressible auxiliary material according to at least one embodiment. FIG. 3 is a partial cross-sectional view of a staple cartridge assembly according to at least one embodiment. FIG. 3 is a partial cross-sectional view of a fixing member inserted into a staple cavity of a staple cartridge according to at least one embodiment. FIG. 3 is a partial cross-sectional view of a compressible auxiliary material according to at least one embodiment. FIG. 3 is a partial cross-sectional view of a compressible auxiliary material according to at least one embodiment. FIG. 3 is a partial perspective view of an alternative compressible aid embedded in a tissue by at least one staple, according to at least one embodiment. It is a partial cross-sectional view of the compressible auxiliary material of FIG. 28 without compression. FIG. 29 is a partial cross-sectional view of FIG. 29 under compression. FIG. 3 is a perspective view of a staple cartridge assembly with an alternative compressible aid according to at least one embodiment. FIG. 3 is a perspective view of a staple cartridge assembly with an alternative compressible aid according to at least one embodiment. FIG. 3 is a partial perspective view of a staple cartridge assembly with implantable auxiliary material according to at least one embodiment. FIG. 33 is a partial perspective view of the auxiliary material of FIG. 33 embedded in the tissue by at least one staple. FIG. 3 is a partial perspective view of an implantable auxiliary material according to at least one embodiment. FIG. 3 is a partial perspective view of an implantable auxiliary material according to at least one alternative embodiment. FIG. 36 is a partial elevation view of the implantable auxiliary material of FIG. It is a detailed figure of the loop knot by at least one embodiment. FIG. 3 is a detailed view of the loop knot utilized by the auxiliary material of FIG. 35, according to at least one embodiment. FIG. 35 is a partial elevation view of the implantable auxiliary material of FIG. FIG. 3 is a partial cross-sectional view of a compressible auxiliary material comprising a plurality of upright fibers according to at least one embodiment described herein. FIG. 3 is a partial cross-sectional view of a compressible auxiliary material comprising a plurality of upright fibers according to at least one embodiment described herein. FIG. 3 is a partial perspective view of a compressible aid embedded in a tissue by at least one staple according to at least one embodiment described herein. FIG. 3 is a partial perspective view of a fiber according to at least one alternative embodiment described herein. FIG. 3 is a partial perspective view of a fiber according to at least one embodiment described herein. FIG. 3 is a partial perspective view of a compressible auxiliary material according to at least one embodiment described herein.

Throughout the drawings, the corresponding reference numerals indicate the corresponding parts. The illustrations described herein illustrate various embodiments of the invention in one embodiment, and such illustrations should be construed as limiting the scope of the invention in any way. do not have.

The applicant of the present application owns the following US patent applications filed on the same day as the present application, the entire contents of which are incorporated herein by reference:
U.S. Patent Application No. ________, Invention Title "IMPLANTABLE LAYER COMPRISING PLASTICALLY DEFORMED FIBERS", Agent Reference No. END7646USNP / 150081,
U.S. Pat.
U.S. Patent Application No. ________, Invention Title "TUBULAR ABSORBABLE CONSTRUCTS", Agent Reference No. END7648USNP / 150083,
U.S. Patent Application No. ________, Invention Title "IMPLANTABLE ADJUNCT COMPRISING BONDED LAYERS", Agent Reference No. END7649USNP / 150084,
U.S. Patent Application No. ________, Invention Title "COMPLESSIBLE ADJUNCTS WITH BONDING NODES", Agent Reference No. END7650USNP / 150085,
US Patent Application No. ________, Invention Name "COMPRESS WITH WITH INTERMEDIATE SUPPORTING STRUCTURES", Agent Reference No. END7651USNP / 150086 US Patent Application No. END7651USNP / 150086 US Patent Application No. ______ No. END7652USNP / 150087,
U.S. Patent Application No. ________, Title of Invention "COMPLESSIBLE ADJUNCT WITH LOOPING MEMBERS", Agent Reference No. END7653USNP / 150088,
US Pat.
US Pat.
US Pat.
US Pat.
US Pat.

The applicant of the present invention also owns the U.S. patent applications set forth below, the United States entitled "SURGICAL INSTRUMENTS WITH RECONFIGURABLE SHAFT SEGMENTS", the entire contents of which are incorporated herein by reference. Patent Application No. 12 / 894,311 (current US Pat. No. 8,763,877),
"SURGICAL STAPLE CARTRIDGES SUPPORTING NON-LINEARLY ARRANGED STAPLES AND SURGICAL STAPLING INSTRUMENTS WITH COMMON STAPLE-FORMING No. 3 / U.S.A.
US Patent Application No. 12 / 894,327 (current US Pat. No. 8,978,956) entitled "JAW Closure ARRANGEMENTS FOR SURGICAL INSTRUMENTS",
U.S. Patent Application No. 12 / 894, 351 (currently U.S. Patent No. 12 / 894, 351) entitled "SURGICAL CUTTING AND FASTENING INSTRUMENTS WITH SEPARATE AND DISTICT FASTENEER DEPLOYMENT AND TISSUE CUTTING SYSTEMS"
U.S. Patent Application No. 12 / 894,338 (current U.S. Patent No. 8,864,007) entitled "IMPLANTABLE FASTENEER CARTRIDGE HAVING A NON-UNIFORM ARRANGEMENT",
U.S. Patent Application No. 12 / 894,369 (current U.S. Patent Application Publication No. 2012/0080344) entitled "IMPLANTABLE FASTENEER CARTRIDGE COMPRISING A SUPPORT RETAINER",
U.S. Patent Application No. 12 / 894, 312 (current U.S. Patent No. 8,925,782) entitled "IMPLANTABLE FASTENEER CARTRIDGE COMPRISING MULTIPLE LAYERS",
U.S. Patent Application No. 12 / 894,377 (current U.S. Patent No. 8,393,514) entitled "SELECTIVELY ORIENTABLE IMPLANTABLE FASTENEER CARTRIDGE",
U.S. Patent Application No. 12 / 894,339 (current U.S. Patent No. 8,840,003) entitled "SURGICAL STAPLING INSTRUMENT WITH COMPACT ARTICULATION CONTROL ARRANGEMENT",
U.S. Patent Application No. 12 / 894,360 (current U.S. Patent No. 9,113,862) entitled "SURGICAL STAPLING INSTRUMENT WITH A VARIALBLE STAPLE FORMING SYSTEM",
U.S. Patent Application No. 12 / 894, 322 (current U.S. Patent No. 8,740,034) entitled "SURGICAL STAPLING INSTRUMENT WITH INTERCHANGE STAPLE CARTRIDGE ARRANGEMENTS",
U.S. Patent Application No. 12 / 894,350 (current U.S. Patent Application Publication No. 2012/0080478) entitled "SURGICAL STAPLE CARTRIDGES WITH DETACHANBLE SUPPORT STRUCTURES",
U.S. Patent Application No. 12 / 894,383 (current U.S. Patent No. 8,752,699) entitled "IMPLANTABLE FASTENEER CARTRIDSING BIOABSORBABLE LAYERS",
U.S. Patent Application No. 12 / 894,389 (current U.S. Pat. No. 8,740,037) entitled "COMPLESSABLE FASTENEER CARTRIDGE",
U.S. Patent Application No. 12 / 894,345, entitled "FASTENERS SUPPORTED BY A FASTENEER CARTRIDGE SUPPORT", (current U.S. Pat. No. 8,783,542),
U.S. Patent Application No. 12 / 894,306 entitled "COLLAPSIBLE FASTENEER CARTRIDGE" (current U.S. Patent No. 9,044,227),
U.S. Patent Application No. 12 / 894,318 (current U.S. Patent No. 8,814,024) entitled "FASTENEER SYSTEM COMPRISING A PLURALITY OF CONNECTED RETENTION MATRIX ELEMENTS",
U.S. Pat.
U.S. Patent Application No. 12 / 894,361 (current U.S. Pat. No. 8,529,600) entitled "FASTENER SYSTEM COMPRISING A RETENTION MATRIX",
U.S. Patent Application No. 12 / 894, 367 (current U.S. Patent No. 9,033,203) entitled "FASTENING INSTRUMENT FOR DEPLOYING A FASTENEER SYSTEM COMPRISING A RETIONION MATRIX",
U.S. Patent Application No. 12 / 894,388 (current U.S. Pat. No. 8,474,677) entitled "FASTENEER SYSTEM COMPRISING A RETENTION MATRIX AND A COVER",
U.S. Patent Application No. 12 / 894,376 (current U.S. Pat. No. 9,044,228) entitled "FASTENER SYSTEM COMPRISING A PLURALITY OF FASTENEER CARTRIDGES",
US Patent Application No. 13 / 097,865 (current US Patent Application Publication No. 2012/0080488) entitled "SURGICAL STAPLER ANVIL COMPRISING A PLURALITY OF FORMING POCKETS",
U.S. Patent Application No. 13 / 097,936 (current U.S. Patent No. 8,657,176) entitled "TISSUE THICKNESS COMPENSATOR FOR A SURGICAL STAPLER",
U.S. Patent Application No. 13 / 097,954 (current U.S. Patent Application Publication No. 2012/0080340) entitled "STAPLE CARTRIDGE COMPRISING A VARIABLE THICKNESS COMPRESSIBLE PORTION",
U.S. Patent Application No. 13 / 097,856 (current U.S. Patent Application Publication No. 2012/0080336) entitled "STAPLE CARTRIGGE COMPRISING STAPLES POSITIONED WITHIN A COMPRESSIBLE PORTION THEREOF".
U.S. Patent Application No. 13 / 097,928 (current U.S. Patent No. 8,746,535) entitled "TISSUE THICKNESS COMPENSATOR COMPRISING DETACHABLE PORTIONS",
U.S. Patent Application No. 13 / 097,891 (current U.S. Patent No. 8,864,009) entitled "TISSUE THICKNESS COMPENSATOR FOR A SURGICAL STAPLER COMPRISING AN ADJUSTABLE ANVIL",
U.S. Patent Application No. 13 / 097,948 (current U.S. Patent No. 8,978,954) entitled "STAPLE CARTRIDGE COMPRISING AN ADJUSTABLE DISTAL PORTION",
U.S. Patent Application No. 13 / 097,907 (current U.S. Patent Application Publication No. 2012/0080338) entitled "COMPLESSLIBLE STAPLE CARTRIDGE ASSEMBLY",
U.S. Patent Application No. 13 / 097,861 (current U.S. Patent No. 9,113,861) entitled "TISSUE THICKNESS COMPENSATOR COMPRISING PORTIONS HAVING DIFFERENT PROPERTIES",
U.S. Patent Application No. 13 / 097,869 (current U.S. Pat. No. 8,857,694) entitled "STAPLE CARTRIDGE LOADING ASSEMBLY",
U.S. Patent Application No. 13 / 097,917 (current U.S. Pat. No. 8,777,004) entitled "COMPLESSIBLE STAPLE CARTRIDGE COMPRISING ALIGNMENT MEMBERS",
U.S. Patent Application No. 13 / 097,873 (current U.S. Pat. No. 8,740,038) entitled "STAPLE CARTRIDGE COMPRISING A RELEASABLE PORTION",
U.S. Patent Application No. 13 / 097,938 (current U.S. Pat. No. 9,016,542) entitled "STAPLE CARTRIDGE COMPRISING COMPRESSIBLE DISSTORTION RESISTANT COMPONENTS",
U.S. Patent Application No. 13 / 097,924 (current U.S. Patent Application Publication No. 2012/0083835) entitled "STAPLE CARTRIDGE COMPRISING A TISSUE THICKNESS COMPENSATOR",
U.S. Patent Application No. 13 / 242,029 (current U.S. Patent No. 8,893,949) entitled "SURGICAL STAPLER WITH FLOATING ANVIL",
U.S. Patent Application No. 13 / 242,066 entitled "CURVED END EFFECTOR FOR A STAPLING INSTRUMENT" (current U.S. Patent Application Publication No. 2012/0080498),
U.S. Patent Application No. 13 / 242,086 (current U.S. Patent No. 9,055,941) entitled "STAPLE CARTRIDGE INCLUDING COLLAPSIBLE DECK",
U.S. Patent Application No. 13 / 241,912 entitled "STAPLE CARTRIDGE INCLUDING COLLAPSIBLE DECK ARRANGEMENT" (current U.S. Patent No. 9,050,084),
U.S. Patent Application No. 13 / 241,922 (current U.S. Patent Application Publication No. 2013/0075449) entitled "SURGICAL STAPLER WITH STATIONARY STAPLE DRIVERS",
U.S. Patent Application No. 13 / 241,637 (current U.S. Patent No. 8,789,741) entitled "SURGICAL INSTRUMENT WITH TRIGGER ASSEMBLY FOR GENERATING MULTIPLE ACTION MOTIONS",
US Patent Application No. 13 / 241,629 (current US Patent Application Publication No. 2012/0074200) entitled "SURGICAL INSTRUMENT WITH SELECTIVELY ARTICULATABLE END EFFECTOR",
U.S. Patent Application No. 13 / 433,096 (current U.S. Patent Application Publication No. 2012/0241496) entitled "TISSUE THICKNESS COMPENSATOR COMPRISING A PLURALITY OF CAPSULES",
U.S. Patent Application No. 13 / 433,103 (current U.S. Patent Application Publication No. 2012/0241498) entitled "TISSUE THICKNESS COMPENSATOR COMPRISING A PLURALITY OF LAYERS",
U.S. Patent Application No. 13 / 433,098 (current U.S. Patent Application Publication No. 2012/0241491) entitled "EXPANDABLE TISSUE THICKNESS COMPENSATOR",
U.S. Patent Application No. 13 / 433,102 (current U.S. Patent Application Publication No. 2012/0241497) entitled "TISSUE THICKNESS COMPENSATOR COMPRISING A RESERVOIR",
U.S. Pat.
U.S. Patent Application No. 13 / 433,136 (current U.S. Patent Application Publication No. 2012/0241492) entitled "TISSUE THICKNESS COMPENSATOR COMPRISING AT LEAST ONE MEDIAMENT",
U.S. Patent Application No. 13 / 433, 141 (current U.S. Patent Application Publication No. 2012/0241493) entitled "TISSUE THICKNESS COMPENSATOR COMPRISING CONTROLLLED RELEASE AND EXPANSION",
U.S. Patent Application No. 13 / 433, 144 (current U.S. Patent Application Publication No. 2012/0241500) entitled "TISSUE THICKNESS COMPENSATOR COMPRISING FIBERS TO PRODUCT A RESILIENT LOAD",
U.S. Patent Application No. 13 / 433,148 (current U.S. Patent Application Publication No. 2012/0241501) entitled "TISSUE THICKNESS COMPENSATOR COMPRISING STRUCTURE TO PRODUCT A RESILIENT LOAD",
U.S. Patent Application No. 13 / 433,155 (current U.S. Patent Application Publication No. 2012/0241502) entitled "TISSUE THICKNESS COMPENSATOR COMPRISING RESILIENT MEMBERS",
U.S. Patent Application No. 13 / 433,163 (current U.S. Patent Application Publication No. 2012/0248169) entitled "METHODS FOR FORMING TISSUE THICKNESS COMPENSATOR ARRANGEMENTS FOR SURGICAL STAPLERS",
US Patent Application No. 13 / 433,167 entitled "TISSUE THICKNESS COMPENSATORS" (current US Patent Application Publication No. 2012/0241503),
US Patent Application No. 13 / 433,175 (current US Patent Application Publication No. 2012/0253298) entitled "LAYERED TISSUE THICKNESS COMPENSATOR",
U.S. Patent Application No. 13 / 433,179 (current U.S. Patent Application Publication No. 2012/0241505) entitled "TISSUE THICKNESS COMPENSATORS FOR CIRCULAR SURGICAL STAPLERS",
US Patent Application No. 13 / 763,028 (current US Patent Application Publication No. 2013/0146643) entitled "ADHESIVE FILM LAMINATE",
U.S. Patent Application No. 13 / 433,115 (current U.S. Patent Application Publication No. 2013/0256372) entitled "TISSUE THICKNESS COMPENSATOR COMPRISING CAPSULES DEFINING A LOW PRESSURE ENVIRONMENT",
U.S. Patent Application No. 13 / 433,118 (current U.S. Patent Application Publication No. 2013/0256365) entitled "TISSUE THICKNESS COMPRENSATOR COMPRISED OF A PLURALITY OF MATERIALS",
U.S. Patent Application No. 13 / 433,135 (current U.S. Patent Application Publication No. 2013/0256382) entitled "MOVABLE MEMBER FOR USE WITH A TISSUE THICKNESS COMPENSATOR",
U.S. Patent Application No. 13 / 433,140 (current U.S. Patent Application Publication No. 2013/0256368) entitled "TISSUE THICKNESS COMPENSATOR AND METHOD FOR MAKING THE SAME",
U.S. Patent Application No. 13 / 433,129 (current U.S. Patent Application Publication No. 2013/0256367) entitled "TISSUE THICKNESS COMPENSATOR COMPRISING A PLURALITY OF MEDIAMENTS",
U.S. Patent Application No. 11/216,562 (current U.S. Pat. No. 7,669,746) entitled "STAPLE CARTRIDGES FOR FORMING STAPLES HAVING DEFFERING FORMED STAPLE HEIGHTS",
US Patent Application No. 11 / 714,049 (current US Patent Application Publication No. 2007/019482) entitled "SURGICAL STAPLING DEVICE WITH ANVIL HAVING STAPLE FORMING POCKETS OF VARYING DEPTHS".
U.S. Patent Application No. 11 / 711,979 (current U.S. Pat. No. 8,317,070) entitled "SURGICAL STAPLING DEVICES THAT PRODUCTS STORMED STAPLES HAVING DIFFERENT LENGTHS",
U.S. Patent Application No. 11 / 711,975 (current U.S. Patent Application Publication No. 2007/0194079) entitled "SURGICAL STAPLING DEVICE WITH STAPLE DRIVERS OF DIFFERENT HEIGHT",
US Pat.
U.S. Patent Application No. 11 / 712,315 entitled "SURGICAL STAPLING DEVICE WITH MULTIPLE STACKED ACTAUTOR WEDGE CAMS FOR DRIVERING STAPLE DRIVERS" (current U.S. Patent No. 7,500,979).
U.S. Patent Application No. 12 / 038,939 (current U.S. Pat. No. 7,934,630) entitled "STAPLE CARTRIDGES FOR FORMING STAPLES HAVING DEFFERING FORMED STAPLE HEIGHTS",
U.S. Patent Application No. 13 / 020,263 (current U.S. Patent No. 8,636,187) entitled "SURGICAL STAPLING SYSTEMS THAT PRODUCE FORMED STAPLES HAVING DIFFERENT LENGTHS",
U.S. Patent Application No. 13 / 118,278 (current U.S. Patent Application Publication No. 2013/118, 278) entitled "ROBOTICALLY-CONTROLLLED SURGICAL STAPLING DEVICES THAT PRODUCTS FORMED STAPLES HAVING DIFFERENT LENGTHS"
U.S. Patent Application No. 13 / 369,629 (current U.S. Patent No. 8,800,838) entitled "ROBOTICALLY-CONTROLLLED CABLE-BASED SURGICAL END EFFECTORS",
U.S. Patent Application No. 12 / 695, 359 (current U.S. Pat. No. 8,464,923) entitled "SURGICAL STAPLING DEVICES FOR FORMING STAPLES WITH DIFFERENT FORMED HEIGHTS",
U.S. Patent Application No. 13/072,923 (current U.S. Patent No. 8,567,656) entitled "STAPLE CARTRIDGES FOR FORMING STAPLES HAVING DEFFERING FORMED STAPLE HIGHTS",
US Patent Application No. 13 / 766,325 (current US Patent Application Publication No. 2013/0256380) entitled "LAYER OF MATERIAL FOR A SURGICAL END EFFECTOR",
US Patent Application No. 13 / 763,078 entitled "ANVIL LAYER ATTACEED TO A PROXIMAL END OF AN END EFFECTOR" (current US Patent Application Publication No. 2013/0256383),
US Patent Application No. 13 / 763,094 (current US Patent Application Publication No. 2013/0256377) entitled "LAYER COMPRISING DEPLOYABLE ATTACHMENT MEMBERS",
U.S. Patent Application No. 13 / 763, 106 (current U.S. Patent Application Publication No. 2013/0256378) entitled "END EFFECTOR COMPRISING A DISSTAL TISSUE ABUTMENT MEMBER",
U.S. Patent Application No. 13 / 433,147 entitled "TISSUE THICKNESS COMPENSATOR COMPRISING CHANNELS" (current U.S. Patent Application Publication No. 2013/0256369),
U.S. Patent Application No. 13 / 763, 112 (current U.S. Patent Application Publication No. 2013/0256379) entitled "SURGICAL STAPLING CARTRIDGE WITH LAYER RETENTION FEATURES",
U.S. Patent Application No. 13 / 763,035 (current U.S. Patent Application Publication No. 2013/0214030) entitled "ACTUATOR FOR RELEASING A TISSUE THICKNESS COMPENSATOR FROM A FASTENEER CARTRIDGE",
U.S. Patent Application No. 13 / 763,042 (current U.S. Patent Application Publication No. 2013/0221063) entitled "RELEASABLE TISSUE THICKNESS COMPENSATOR AND FASTENEER CARTRIER CARTRIDGE HAVING THE SAME",
U.S. Patent Application No. 13 / 763,048 (current U.S. Patent Application Publication No. 2013/0221064) entitled "FASTENEER CARTRIDGE COMPRISING A RELEASABLE TISSUE THICKNESS COMPENSATOR",
U.S. Patent Application No. 13 / 763,054 (current U.S. Patent Application Publication No. 2014/097227) entitled "FASTENEER CARTRIDGE COMPRISING A CUTTING MEMBER FOR RELEASING A TISSUE THICKNESS COMPENSATOR",
U.S. Patent Application No. 13 / 763,065 (current U.S. Patent Application Publication No. 2013/0221065) entitled "FASTENEER CARTRIDGE COMPRISING A RELEASABLY ATTACEED TISSUE THICKNESS COMPENSATOR",
U.S. Patent Application No. 13 / 763,021 (current U.S. Patent Application Publication No. 2014/0224686) entitled "STAPLE CARTRIDGE COMPRISING A RELEASABLE COVER",
US Patent Application No. 13 / 763,078 entitled "ANVIL LAYER ATTACEED TO A PROXIMAL END OF AN END EFFECTOR" (current US Patent Application Publication No. 2013/0256383),
US Patent Application No. 13 / 763,095 entitled "LAYER ARRANGEMENTS FOR SURGICAL STAPLE CARTRIDGES" (current US Patent Application Publication No. 2013/0161374),
US Patent Application No. 13 / 763,147 entitled "IMPLANTABLE ARRANGEMENTS FOR SURGICAL STAPLE CARTRIDGES" (current US Patent Application Publication No. 2013/015636),
US Pat.
U.S. Patent Application No. 13 / 763, 161 (current U.S. Patent Application Publication No. 2013/0153641) entitled "RELEASABLE LAYER OF MATERIAL AND SURGICAL END EFFECTOR HAVING THE SAME",
U.S. Patent Application No. 13 / 763,177 (current U.S. Patent Application Publication No. 2013/0146641) entitled "ACTUATOR FOR RELEASING A LAYER OF MATERIAL FROM A SURGICAL END EFFECTOR",
U.S. Patent Application No. 13 / 763,037 (current U.S. Patent Application Publication No. 2014/0224857) entitled "STAPLE CARTRIDGE COMPRISING A COMPRESSIBLE PORTION",
U.S. Patent Application No. 13 / 433,126 (current U.S. Patent Application Publication No. 2013/0256366) entitled "TISSUE THICKNESS COMPENSATOR COMPRISING TISSUE INGROWTH FEATURES",
U.S. Patent Application No. 13 / 433, 132 (current U.S. Patent Application No. 13 / 433, 132) entitled "DEVICES AND METHODS FOR ATTACHING TISSUE THICKNESS COMPENSATING MATERIALS TO SURGICAL STAPLING INSTRUMENTS"
U.S. Patent Application No. 13 / 851,703 (current U.S. Patent Application Publication No. 2014/0291382) entitled "FASTENEER CARTRIDGE COMPRISING A TISSUE THICKNESS COMPENSATOR INCLUDING OPENINGS THEREIN",
U.S. Patent Application No. 13 / 851,676 (current U.S. Patent Application Publication No. 2014/0291379) entitled "TISSUE THICKNESS COMPENSATOR COMPRISING A CUTTING MEMBER PHAT",
US Pat.
U.S. Patent Application No. 13 / 851,684 (current U.S. Patent Application Publication No. 2014/0291380) entitled "FASTENEER CARTRIDGE COMPRISING A TISSUE THICKNESS COMPENSATOR AND A GAP SETTING ELEMENT",
U.S. Patent Application No. 14 / 187,387 (current U.S. Patent Application Publication No. 2014/01662724) entitled "STAPLE CARTRIDGE INCLUDING A BARBED STAPLE",
U.S. Patent Application No. 14 / 187,395 (current U.S. Patent Application Publication No. 2014/01662725) entitled "STAPLE CARTRIDGE INCLUDING A BARBED STAPLE",
U.S. Patent Application No. 14 / 187,400 entitled "STAPLE CARTRIDGE INCLUDING A BARBED STAPLE" (current U.S. Patent Application Publication No. 2014/01662726),
U.S. Patent Application No. 14 / 187, 383 (currently U.S. Patent Application No. 14 / 187, 383) entitled "IMPLANTABLE LAYERS AND METHODS FOR ALTERING IMPLANTABLE LAYERS FOR USE WITH SURGICAL FASTENING INSTRUMENTS"
U.S. Patent Application No. 38/20
"IMPLANTABLE LAYERS AND METHODS FOR MODEFYING THE SHAPE OF THE IMPLANTABLE LAYERS FOR USE WITH A SURGICAL FASTENING INSTRUMENT" No. 38, No. 18 of the United States, No. 18 of the United States, No.
U.S. Patent Application No. 14 / 187,389 entitled "IMPLANTABLE LAYER ASSEMBLES" (current U.S. Patent Application Publication No. 2015/0238187),
U.S. Patent Application No. 14 / 187,385 entitled "IMPLANTABLE LAYERS COMPRISING A PRESSRED REGION" (current U.S. Patent Application Publication No. 2015/0238191),
US Patent Application Nos. 14 / 187,384 entitled "FASTENING SYSTEM COMPRISING A FIRING MEMBER LOCKOUT" (current US Patent Application Publication No. 2015/0238186),
U.S. Patent Application No. 14 / 827,856, entitled "IMPLANTABLE LAYERS FOR A SURGICAL INSTRUMENT",
U.S. Patent Application No. 14 / 827,907, entitled "IMPLANTABLE LAYERS FOR A SURGICAL INSTRUMENT",
U.S. Patent Application No. 14 / 827,932, entitled "IMPLANTABLE LAYERS FOR A SURGICAL INSTRUMENT",
U.S. Patent Application No. 14 / 667,874, entitled "MALLEABLE BIOABSORBABLE POLYMER ADHESIVE FOR RELEASABLY ATTACCHING A STAPLE BUTTRESS TO A SURGICAL STAPLER",
US Patent Application No. 14 / 300,954, entitled "ADJUNCT MATERIALS AND METHODS OF USING SAME IN SURGICAL METHODS FOR TISSUE SEALING",
US Patent Application No. 14 / 840,613, entitled "DRUG ELUTING ADJUNCTS AND METHODS OF USING DRUG ELUTING ADJUNCTS",
U.S. Patent Application Nos. 14 / 498, 145 entitled "METHOD FOR CREATEING A FLEXIBLE STAPLE LINE" and "IMPLANTABLE ADJUNCT SYSTEMS FOR DETERMINING ADJUNCT SKEW" 14 U.S.

Many specific details are provided to provide a complete understanding of the overall structure, function, manufacture, and use of embodiments described herein and shown in the accompanying drawings. Well-known behaviors, components, and elements are not described in detail to avoid obscuring the embodiments described herein. It is understood by the reader that the embodiments described and illustrated herein are non-limiting examples, and therefore the particular structural and functional details disclosed herein are exemplary and exemplary. It will be understood to get. Modifications and changes to them can be made without departing from the claims.

The terms "comprise" (any form of comprise, such as "comprises" and "comprising"), "have" (any form of have, such as "has" and "having"), "include ( ”(Any form of include, such as“ includes ”and“ inclusion ”), and“ contain ”(any form of content, such as“ context ”and“ connecting ”) are open concatenations. It is a verb. As a result, a surgical system, device, or device that "equipped", "has", "contains", or "contains" one or more elements is one or more of them. It has elements, but is not limited to having only one or more of them. Similarly, a system, device, or device element that "includes", "has", "contains", or "contains" one or more features is one or more of them. However, it is not limited to having only one or more of these characteristics.

The terms "proximal" and "distal" are used herein with reference to the clinician operating the handle portion of the surgical instrument. The term "proximal" refers to the part closest to the clinician and the term "distal" refers to the part located away from the clinician. For convenience and clarity, it is further understood that spatial terms such as "vertical", "horizontal", "top", and "bottom" can be used with respect to the drawings herein. Let's go. However, surgical instruments are used in many orientations and positions, and these terms are not intended to be limited and / or absolute.

Various exemplary devices and methods are provided for performing laparoscopic and minimally invasive surgical procedures. However, it is readily appreciated by the reader that the various methods and devices disclosed herein can be used in many surgical procedures and applications, including those associated with, for example, open surgical procedures. Will be done. By reading "forms for carrying out the invention" herein, the reader may read that the various instruments disclosed herein are incisions or punctures formed in the tissue, eg, through a natural opening. You will further recognize that it can be inserted into the body in any way, such as through a hole. The working part or end effector part of these instruments can be inserted directly into the patient's body or through an access device with a passage of action capable of advancing the end effector and elongated shaft of the surgical instrument. You can also do it.

The surgical staple system can include a shaft and an end effector extending from the shaft. The end effector includes a first jaw portion and a second jaw portion. The first jaw comprises a staple cartridge. The staple cartridge is insertable into and removable from the first jaw, but the staple cartridge is not removable from the first jaw, or at least not easily replaceable. Other embodiments are also envisioned. The second jaw comprises an anvil configured to deform the staple ejected from the staple cartridge. The second jaw is pivotable about the closed axis with respect to the first jaw, while the first jaw is pivotable with respect to the second jaw. Embodiments are also envisioned. The surgical staple fastening system further comprises a joint that is configured to allow the end effector to rotate, ie, range of motion, with respect to the shaft. The end effector is rotatable about a range of motion that extends through the joint. Other embodiments that do not include joints are also envisioned.

The staple cartridge includes a cartridge body. The cartridge body includes a proximal end, a distal end, and a deck extending between the proximal and distal ends. In use, the staple cartridge is located on the first side of the tissue to be stapled and the anvil is located on the second side of the tissue. The anvil is moved towards the staple cartridge to compress and clamp the tissue against the deck. Subsequently, staples detachably stored in the cartridge body can be subsequently deployed within the tissue. The cartridge body includes a staple cavity defined therein, and the staples are detachably stored in the staple cavity. The staple cavities are arranged in six longitudinal rows. The three rows of staple cavities are located on the first side of the longitudinal slot and the three rows of staple cavities are located on the second side of the longitudinal slot. Staple cavities and other arrangements of staples are also possible.

The staples are supported by a staple driver inside the cartridge body. The driver can move between a first, i.e., unlaunched position and a second, i.e., fired position, which ejects the staples from the staple cavity. The driver is an elastic member configured to be held within the cartridge body by a retainer extending around the bottom of the cartridge body, to grip the cartridge body, and to hold the holder against the cartridge body. include. The driver can move between their unfired position and their fired position by a thread. The thread is mobile between the proximal position adjacent to the proximal end and the distal position adjacent to the distal end. The thread has multiple ramps that slide under the driver and are configured to lift the driver, on which the staples are supported and towards the anvil.

In addition to the above, the thread is moved distally by the launcher. The launcher is configured to contact the thread and push the thread towards the distal end. Longitudinal slots defined within the cartridge body are configured to accommodate launching members. The anvil also includes a slot configured to receive the launching member. The launching member further comprises a first cam that engages the first jaw and a second cam that engages the second jaw. As the launcher is advanced distally, the first and second cams can control the distance between the deck of the staple cartridge and the anvil, i.e. the tissue gap. The launcher also comprises a knife configured to incise the tissue trapped between the staple cartridge and the anvil. It is desirable that the knife be positioned at least partially proximal to the slope so that the staples are ejected forward of the knife.

Also, the staple cartridge may include an embeddable layer. The embeddable layer is configured to be captured within the staple with the tissue when the staple is deployed by the corresponding driver. The implantable layer may include buttresses, tissue thickness compensators, and / or other auxiliary materials. The tissue thickness compensator is configured to compensate for changes in tissue properties, such as changes in tissue thickness along staple lines. The tissue thickness compensator can be compressible and elastic. In use, the tissue thickness compensator promotes proper tissue compression within and between staples while preventing or limiting excessive compression of stapled tissue.

The embeddable layer of the staple cartridge may be detachably secured to the body of the staple cartridge. For example, the implantable layer may be detachably secured to the deck of the staple cartridge using a removable adhesive, at least one mounting tab, and / or other mounting mechanism. In addition to or instead, the implantable layer may be detachably secured to the first or second jaw. The implantable layer may be located, for example, on the cartridge side of the end effector and / or on the anvil side of the end effector.

The implantable layer may be configured to promote internal growth of the tissue. In various cases, tissue into an implantable layer to facilitate healing of the tissue to be treated (eg, stapled and / or incised tissue) and / or to accelerate patient recovery. It is desirable to promote the internal growth of the. More specifically, internal growth of tissue into the implantable layer may reduce the incidence, extent, and / or duration of inflammation at the surgical site. Internal growth of tissue inside and / or around the implantable layer can control the transmission of infection, for example, at the surgical site. For example, the internal growth of blood vessels, especially leukocytes, inside and / or around the implantable layer can combat infections inside and / or around the implantable layer and adjacent tissues. Internal growth of tissue can also aid the patient's body in accepting foreign bodies (eg, implantable layers and staples) and can reduce the likelihood that the patient's body will reject the foreign body. Rejection of foreign bodies can cause infections and / or inflammation at the surgical site.

Referring to the drawings, similar reference numerals indicate similar components through several figures, and FIG. 1 is an exemplary suitable for use with implantable aids such as tissue thickness compensators. A surgical staple fastening and cutting instrument 8010 is shown. The surgical stapler and cutting instrument 8010 may be equipped with an anvil 8014, which can be repeatedly opened and closed to an elongated staple channel 8016 around a pivot attachment. The staple application assembly 8012 may include an anvil 8014 and a channel 8016, which assembly 8012 may be attached proximally to the elongated shaft 8018 forming the execution portion 8022. When the staple application assembly 8012 is closed, or at least substantially closed, the execution portion 8022 may exhibit a sufficiently small cross section suitable for inserting the staple assembly 8012 through the trocar.

Under various circumstances, the staple cartridge assembly 8012 is operated by a handle 8020 connected to an elongated shaft 8018. The handle 8020 is a closure that can be pivoted in front of the pistol grip 8036 to close the elongated shaft 8018 and the rotary knob 8030 that rotates the staple application assembly 8012 around the longitudinal axis of the elongated shaft 8018, as well as the staple application assembly 8012. It may be equipped with a user control device such as a trigger 8026. The closure release button 8038 is presented outward on the handle 8020 when the closure trigger 8026 is tightened, so that the release button 8038 is, for example, to untighten the closure trigger 8026 and open the staple application assembly 8012. , Can be pressed.

The firing trigger 8034 is capable of pivoting in front of the closing trigger 8026 and causes the staple application assembly 8012 to stap and staple the tissue clamped therein. In various situations, multiple firing strokes can be used using the firing trigger 8034 to reduce the amount of force required to be applied by the surgeon's hand per stroke. In certain embodiments, the handle 8020 may include one or more rotary indicator wheels, such as, for example, a rotary indicator wheel 8041 capable of indicating launch progress. The manual launch release lever 8042 can, if desired, retract the launch system before the complete launch stroke is complete, and in addition, the launch release lever 8042 causes the launch system to become stuck and / or non-functional. Allows the surgeon or other clinician to retract the launch system in such cases.

Further details regarding the surgical stapler and cutting instrument 8010 and other surgical stapler and cutting instruments suitable for use with the present disclosure are incorporated herein by reference in their entirety. , US Patent Application No. 13 / 851,693, filed March 27, 2013, in the title of the invention "FASTENEER CARTRIDGE ASSEMBLY". In addition, motorized surgical staples and cutting instruments may also be used with this disclosure. See, for example, US Patent Application Publication No. 2009/090763A1, filed August 8, 2008, the title of the invention, "POWERED SURGICAL STAPLING DEVICE," the entire disclosure of which is incorporated herein by reference.

Referring to FIGS. 2 and 3, a launch assembly, such as the launch assembly 9090, can be utilized with a surgical staple fastener and cutting instrument 8010 to advance the wedge thread 9126, the wedge thread 9126 from the staple application assembly 8012. It comprises a plurality of wedges 9204 configured to deploy the staples into the tissue captured between the anvil 8014 and the elongated staple channel 8016. In addition, an E-beam 9102 located in the distal portion of the launch assembly 9090 may launch staples from the staple application assembly 8012 and may position the anvil 8014 with respect to the elongated staple channel 8016 during launch. The E-beam 9102 captures a pair of upper pins 9110, a pair of central pins 9112 that may be driven by portion 9218 of the wedge thread 9126, a lower pin or foot 9114, and the launch assembly 9090 as it is advanced distally. Includes a sharp cut edge 9116 that may be configured to cut the cut tissue. In addition, the integrally formed and proximally projecting upper guide 9118 and central guide 9120, which carry each vertical end of the cutting edge 9116, further sharply cut the tissue prior to being cut. Tissue staging areas 9122 may be defined to assist in guiding to the edges 9116. The intermediate guide 9120 also engages with the staple application assembly 8012 and launches the staple application assembly 8012 by abutting on the stepped central member 9124 of the wedge thread 9126 (FIG. 2) that realizes staple forming with the staple application assembly 8012. Can work to do.

Under various circumstances, the staple cartridge may provide a means for compensating for the thickness of tissue trapped within the staples deployed from the staple cartridge. Referring to FIG. 4, a staple cartridge such as a staple cartridge 10000 can be used, for example, with a surgical staple fastener and cutting instrument 8010, and also with a first portion of rigidity such as, for example, a support portion 10010, for example. It may include a second portion of compressibility such as tissue thickness compensator 10020. The support portion 10010 may include a cartridge body and a plurality of staple cavities 10012. For example, the staples 10030 can be removably placed within each staple cavity 10012. Primarily with reference to FIGS. 4 and 5, each staple 10030 may include a base 10031 and one or more legs 10032 extending from the base 10031. Prior to the deployment of the staple 10030, the base 10031 of the staple 10030 may be supported by a staple driver disposed within the support portion 10010, while the leg portion 10032 of the staple 10030 is at least partially contained within the staple cavity 10012. Can be accommodated.

In various situations, the staple 10030 is an anvil in which the leg 10032 moves through the tissue thickness compensator 10020, penetrates the top surface of the tissue thickness compensator 10020, penetrates the tissue T, and is placed opposite the staple cartridge 10000. Can be deployed between unlaunched and fired positions to contact with. When the leg 10032 hits the anvil and deforms, the leg 10032 of each staple 10030 captures a part of the tissue thickness compensator 10020 and a part of the tissue T in each staple 10030 and applies a compressive force to this tissue. be able to. In addition to the above, the leg 10032 of each staple 10030 can be deformed downward towards the base 10031 of the staple so that the tissue T and the tissue thickness compensator 10020 form a staple trapping region therein. .. Under various circumstances, the staple capture area can be defined between the inner surface of the deformed leg 10032 and the inner surface of the base 10031. The size of the staple capture area may depend on several factors, for example, the length of the leg, the diameter of the leg, the width of the base, and / or the degree of deformation of the leg.

In use, in addition to the above, and primarily with reference to FIG. 4, anvils such as the surgical stapler and cutting instrument 8010 anvil 8014 are stapled cartridges by pressing the closure trigger 8026 to advance the E-beam 9102. It can be moved to the closed position on the opposite side of 10000. The anvil 8014 may place tissue against the tissue thickness compensator 10020 and, under various circumstances, may compress the tissue thickness compensator 10020, for example, against the support portion 10010. Once the anvil 8014 is properly placed, the staples 10030 can also be deployed as shown in FIG.

Under various circumstances, as mentioned above, the staple firing thread 10050 is in many respects similar to thread 9126 (see FIG. 3) and, as shown in FIG. 5, the proximal end of the staple cartridge 10000. It can be moved from the thread towards the distal end 10002. When the launch assembly 9090 is advanced, the thread 10050 can contact the staple driver 10040 and lift the staple driver 10040 upward in the staple cavity 10012. In at least one example, the thread 10050 and the staple driver 10040 may each have one or more slopes or slanted surfaces that may work together to move the staple driver 10040 upward from an unlaunched position. When the staple driver 10040 is lifted upward in each staple cavity 10012, the staple driver 10040 lifts the staple 10030 upward so that the staple 10030 can emerge from the staple cavity 10012. Under various circumstances, thread 10050 may move multiple staples upward at the same time as part of the firing sequence.

With reference to FIG. 5, the staple leg 10032 of the staple 10030 may extend beyond the support portion 10010 into the compensator 10020 when the staple 10030 is in the unlaunched position. Under various circumstances, when the staple 10030 is in the unlaunched position, the tip of the staple leg 10032, or any other part of the staple leg 10032, protrudes through the upper tissue contact surface 10021 of the tissue thickness compensator 10020. I don't get it. Under certain circumstances, the tip of the staple leg 10032 may be provided with a sharp tip capable of incising and penetrating the tissue thickness compensator 10020.

With reference to FIG. 6, the staple cartridge assembly 10 is shown. The staple cartridge assembly 10 includes a staple cartridge 12 that can be used with surgical staple fasteners and cutting instruments 8010. The staple cartridge 12 is similar to the staple cartridge 10000 in many respects. Like the staple cartridge 10000, the staple cartridge 12 has a plurality of staples 10030, which are housed in a plurality of cavities or pockets defined within the staple cartridge 12. Also, the plurality of staples 10030 of the staple cartridge 12 may be deployed in a firing sequence of surgical staple fasteners and cutting instruments 8010.

The staple cartridge 12 further includes a cartridge deck 16 and a knife slot 37 (FIGS. 14 and 16), the knife slot 37 for cutting the tissue captured by the surgical staple fastener and cutting instrument 8010 by the cutting edge 9116. Accommodates its cutting edge 9116 as it is advanced. By advancing the thread 10050 through the staple cartridge 12, as described above, the staples 10030 of the staple cartridges 12 are respectively deployed in the same or substantially the same manner as the staples 10030 are deployed from the staple cartridges 10000. It will be deployed from the pocket into the tissue.

Referring again to FIG. 6, the staple cartridge assembly 10 further comprises a tissue thickness compensator or compressible aid 11 similar to the tissue thickness compensator 10020 in many respects. The compressible auxiliary material 11 is arranged with respect to the cartridge deck 16. The compressible auxiliary material 11 is attached to the cartridge deck 16. For example, the compressible auxiliary material 11 may be partially melted onto the cartridge deck 16 and then resolidified by cooling, whereby the compressible auxiliary material 11 will be coupled to the cartridge deck 16. Further, various attachment mechanisms can be used to attach the compressible auxiliary material 11 to the cartridge deck 16.

The compressible auxiliary material 11 includes a first biocompatible layer 14 disposed with respect to the cartridge deck 16 and / or configured to adhere to the cartridge deck 16, plus an anvil 8014 and a staple cartridge. Includes a second biocompatible layer 15 configured to be placed with respect to the tissue captured between 12 and 12. The first biocompatible layer 14 and the second biocompatible layer 15 extend or extend between the first biocompatible layer 14 and the second biocompatible layer 15, as shown in FIG. It is separated by a plurality of supporting members or columns 19 that stand up. The stanchion 19 maintains an average distance between the first biocompatible layer 14 and the second biocompatible layer 15, which is partially defined by the average height (H) of the stanchion 19.

As shown in FIG. 6, the stanchions 19 have the same or at least substantially the same height (H). Instead, in certain cases, the stanchions 19 may have varying heights. Further, as shown in FIG. 6, the stanchions 19 have the same or at least substantially the same cross-sectional areas. Alternatively, the stanchion 19 may have various cross-sectional areas. In at least one case, the cross-sectional area of the stanchion 19 may vary along the height (H) of the stanchion 19. For example, the stanchion 19 may have a wide intermediate section and a narrow end section. Alternatively, the stanchion 19 may have a narrow intermediate section and a wide end section. Alternatively, the stanchion 19 may have a wide intermediate section, one wide end section, and one narrow end section. Alternatively, the stanchion 19 may have a narrow intermediate section, one narrow end section, and one wide end section.

As shown in FIG. 6, the stanchion 19 has a circular or at least substantially circular cross-sectional area. Alternatively, one or more of the columns 19 may have a non-circular cross-sectional area. In at least one example, one or more of the columns 19 may have an egg-shaped, clover-shaped, crescent-shaped, or triangular cross-sectional area. Other shapes of the cross-sectional area of the stanchion 19 are also contemplated by the present disclosure.

In general, the material composition, height, and / or cross-sectional area of the stanchion 19 at least partially controls its rigidity or ability to flex under compression, and then that ability at least reduces the compressibility of the compressible aid 11. Partially control. Therefore, the stanchion 19 may be configured to adjust the compressibility of the compressible aid 11 to one or more desired values. Various sections of the compressible auxiliary material 11 may have, for example, struts 19 having different stiffness or compressibility.

The stanchions 19 are flexible under the compressive force applied to the compressible aid 11 as the anvil 8014 is moved to the closed position on the opposite side of the staple cartridge 12. Due to the elasticity of the stanchions 19, the compressible aid 11 keeps the average distance between the anvil 8014 and the staple cartridge 12 the same or at least substantially the same during the firing sequence of the surgical stapler and cutting instrument 8010. On the other hand, it becomes possible to adapt to a tissue (T) having a tissue portion having various tissue thicknesses.

As shown in FIG. 6A, the staple 10030 is fired into the compressible aid 11 and the tissue (T), where the tissue (T) is with the first tissue portion 72 having an average tissue thickness (T1). A second tissue portion 74 having an average tissue thickness (T2) thicker than the tissue thickness (T1). The fired staple 10030 defines a space therein for accommodating the captured compressible aid 11 and the captured tissue (T). The space defined by the fired staple 10030 is at least partially limited by the height (H3) of the fired staple 10030, as shown in FIG. 6A. The sum of the final thickness of the captured tissue (T) and the final height of the crushed compressible aid 11 is equal to or at least substantially the height of the launched staple 10030 (H3). Will be equal. In order to compensate for the variation in the thickness of the captured structure (T), the portion arranged with respect to the second structure portion (T2) of the compressible auxiliary material 11 is the compressible auxiliary material 11. It is compressed to a final height (H2) higher than the final height (H1) of the portion arranged with respect to the first tissue portion (T1) of. This elasticity of the stanchions 19 allows the compressible auxiliary material 11 to be compressed with respect to the second tissue portion 74 to a higher degree than the first tissue portion 72, thereby allowing the compressible auxiliary material to be compressed. The eleven can compensate for the various thicknesses of the tissue portions 72 and 74 in the space defined by the fired staple 10030.

When the anvil 8014 is moved to the closed position, the anvil 8014 may come into contact with the tissue T and apply compressive force to the tissue T and the compressible aid 11. The material composition, porosity, power, dimensions, and / or orientation of the stanchions 19 can be adjusted to control or tune the compressibility of the compressible aid 11.

In certain cases, the stanchions 19 can be tilted or skewed to choose a cohesive crush in a first direction, for example in response to compressive forces, such as the proximal direction (P). In other cases, however, the stanchion 19 may be tilted or skewed to choose a cohesive crush in a second direction different from the first, such as the distal direction (D) in response to compressive forces. .. In certain cases, the compressible aid 11 has a first group of struts 19 that are tilted or skewed to select bending in the first direction, and bending in a second direction that is different from the first direction. It may have a second group of stanchions 19 that are tilted or skewed to choose. In such cases, the various bending directions can bend the compressible aid 11 in a disjointed manner.

Referring to FIG. 6, the struts 19 are oriented such that each stanchion 19 extends along the horizontal axis intersecting the first biocompatible layer 14 and the second biocompatible layer 15, or at least substantially extends. Has been done. The stanchions 19 are perpendicular to, or at least substantially perpendicular to, the first biocompatible layer 14 and the second biocompatible layer 15. Therefore, the columns 19 extend parallel to each other or at least substantially parallel to each other. As shown in FIG. 6, the columns 19 are separated from each other and are arranged in parallel rows.

In certain cases, the stanchions 19 are slanted or oriented with respect to the first biocompatible layer 14 and / or the second biocompatible layer 15. In a particular case, the stanchions 19 are configured in a predetermined pattern, for example in concentric circles. The frequency of the stanchions 19 within a particular section of the compressible aid 11 can, among other things, affect the compressibility of such sections. In certain cases, the columns may be systematically concentrated in such sections, for example to increase column strength in certain sections of the compressible aid 11. In at least one case, the stanchion 19 may be concentrated in a section of the compressible aid 11 configured to receive staples when the surgical stapler and cutting instrument 8010 is fired. Instead, the stanchions 19 may be concentrated in the section of the compressible aid 11 that does not accept the staples when the surgical stapler and cutting instrument 8010 is fired. In certain cases, the struts 19 are arranged around the perimeter, thereby defining the sidewalls of the compressible aid 11, as shown in FIG.

Each of the stanchions 19 is an intermediate stand extending between a first termination portion 18 fixed to a first biocompatibility layer 14 and a second termination portion 20 fixed to a second biocompatibility layer 15. Includes portion 22. The termination portions 18 and 20 may be embedded in the first biocompatible layer 14 and the second biocompatible layer 15, respectively. For example, the termination portions 18 and 20 may be woven or woven into the first biocompatible layer 14 and the second biocompatible layer 15, respectively. In certain cases, the termination portions 18 and 20 can be welded onto the first biocompatible layer 14 and the second biocompatible layer 15 using heat or solvent, respectively. In certain cases, the termination portions 18 and 20 may be adhered to, hooked and / or fastened to the first biocompatible layer 14 and the second biocompatible layer 15, respectively.

As shown in FIG. 6, the first biocompatibility layer 14 and the second biocompatibility layer 15 are textile layers. In certain cases, the first biocompatible layer 14 and / or the second biocompatible layer 15 can be a knitted layer. In certain cases, the first biocompatible layer 14 and / or the second biocompatible layer 15 can be a foam layer. In certain cases, the first biocompatible layer 14 and / or the second biocompatible layer 15 can be a film layer.

Referring to FIG. 6B, the compressible auxiliary material 61 is stapled to the structure (T). The compressible auxiliary material 61 includes a first biocompatible layer 64, the first biocompatible layer 64 being disposed with respect to the cartridge deck 16 of the staple cartridge 12 and / or on the cartridge deck 16 of the staple cartridge 12. It is configured to be attached. The loop member 69 projects from the first biocompatible layer 64. The loop member 69 is placed directly with respect to the tissue captured between the anvil 8014 and the staple cartridge 12. Alternatively, the compressible auxiliary material 61 may include the presence of a second biocompatible layer, and the loop member 69 may maintain an average distance or separation distance between the biocompatible layers. In other words, the loop member 69 may lift or raise a second biocompatibility layer onto the first biocompatibility layer 64.

The first biocompatible layer 64 and / or the second biocompatible layer can be a textile layer. In certain cases, the first biocompatible layer 64 and / or the second biocompatible layer can be a knitted layer. In certain cases, the first biocompatible layer 64 and / or the second biocompatible layer can be a foam layer. In certain cases, the first biocompatible layer 64 and / or the second biocompatible layer can be a film layer. One or more strips, eg, monofilament and / or multifilament fibers, to form one or more loop members 69 by various techniques such as weaving and / or knitting. Soft members can be used. In at least one case, for example, the elongated soft member may be passed through the first biocompatible layer 64 to form a loop member 69.

As shown in FIG. 6B, the loop member 69 has an intermediate curved portion extending between the first termination portion 69a, the second termination portion 69b, and the first termination portion 69a and the second termination portion 69b. Includes 69c. The termination portions 69a and 69b are partially embedded and / or adhered to the first biocompatible layer 64, while the intermediate curved portion 69c is a first termination portion 69a and a second termination portion 69b. Is lifted or separated from the first biocompatible layer 64 by. The loop member 69 may have the same or at least substantially the same height. Instead, in certain cases, the loop member 69 may have varying heights.

If a second biocompatible layer is present, for example, the loop member 69 may be placed between the first biocompatible layer 64 and the second biocompatible layer, with the intermediate curved portion 69c being the second. Can adhere to the biocompatible layer of. Various adhesion techniques, such as the use of biocompatible adhesives, can be used to secure the second biocompatible layer to the intermediate curved portion 69c. In certain cases, the intermediate curved portion 69c may be sewn to a second biocompatible layer.

As shown in FIG. 6B, the first biocompatible layer 64 comprises mooring islands 62 separated from each other. The mooring islands 62 are arranged in parallel or at least substantially parallel rows. Each mooring island 62 is defined by a first termination portion 69a and a second termination portion 69b of the loop member 69 intersecting at the mooring island 62. In certain cases, the termination portions 69a and 69b of the loop member 69 may be received, for example, by two mooring islands 62 separated from each other. In certain cases, for example, only a single termination portion 69a or 69b will accept the mooring island 62. Alternatively, for example, the mooring island 62 may be configured to receive three or more of the termination portions 69a and / or 69b. The mooring island 62 may be configured to accept, for example, one or more of the termination portions 69a, but not any of the termination portions 69b.

In addition to the above, one or more of the loop members 69 includes a narrow neck portion 63a extending from the mooring island 62 and a wide head portion 63b extending from the narrow neck portion 63a. In certain cases, the head portion 63b may be disposed with respect to a second biocompatible layer. Instead, the head portion 63b may be placed relative to the tissue (T).

As shown in FIG. 6B, the loop member 69 projects from the first biocompatible layer 64 in a substantially vertical direction, whereby the loop member 69 is placed with respect to the compressible auxiliary material 61 (T). ) Will be bent in a disorganized manner in response to the compressive force transmitted through. In certain cases, the loop member 69 may be tilted or skewed to select a cohesive crush in a first direction, such as in response to a compressive force (P). In other cases, however, the loop member 69 is tilted or skewed to select a cohesive crush in a second direction different from the first, such as the distal direction (D) in response to compressive forces. obtain. In certain cases, the compressible aid 61 has a first group of loop members 69 tilted or skewed to select bending in the first direction and in a second direction different from the first direction. It may include a second group of loop members 69 that are tilted or skewed to choose a bend. In such cases, various bending directions can bend the compressible auxiliary material 69 in a disjointed manner.

Referring to FIG. 7, the compressible auxiliary material 31 includes a first biocompatible layer 34 and a second biocompatible layer 35, which are perforated film layers, as will be described in more detail below. The compressible auxiliary material 31 is similar to the compressible auxiliary material 11 in many respects. For example, the compressible auxiliary material 31 includes a plurality of columns 39 similar to the column 19 of the compressible auxiliary material 11 in many respects. Unlike the stanchions 19, the stanchions 39 are not arranged in parallel rows. Although the struts 39 are configured to intersect each other, the stability of the compressible aid 31 can be improved by improving resistance to crushing under shear and / or compressive loads.

As shown in FIG. 7, the support column 39a is configured to intersect the support column 39b. In the first termination portion 38a of the support column 39a, the first horizontal axis defined by the first termination portion 38a and the second termination portion 40b is relative to the biocompatibility layer 34 and the second biocompatibility layer 35. It is aligned with the second end portion 40b of the column 39b so as to be vertical. Similarly, in the first termination portion 38b of the support column 39b, the second horizontal axis defined by the first termination portion 38b and the second termination portion 40a is the biocompatibility layer 34 and the second biocompatibility layer. It is aligned with the second end portion 40a of the column 39a so as to be perpendicular to 35. Further, the intermediate portions 42a and 42b of the columns 39a and 39b can be attached to each other by, for example, welding. Instead, the intermediate portions 42a and 42b may be able to move freely with respect to each other.

In different configuration arrangements, the particular strut 39 may be configured to share a connecting node or boundary. As shown in FIG. 7, the strut 39c and the strut 39d are attached to the first biocompatible layer 34 at the connecting node 44. The struts 39c and 39d extend from the junction 44 in various directions and terminate at two different attachment nodes 46 and 48 on the second biocompatible layer 35. In addition, the struts 39e extend from the junction 48 and terminate at the junction 49 on the first biocompatible layer 34. Repeated configuration arrangements of struts 39c-39e between the biocompatible layers 34 and 35 can result in a zigzag pattern between them. It should be understood that three or more struts 39 may extend or emerge from one connecting node.

In addition to the above, perforated films of biocompatible layers 34 and 35 can be produced by punching holes 50 in the films. The holes 50 may improve the internal growth of the tissue into the compressible aid 31. In certain cases, the holes 50 are created after the film has been prepared. For example, a solvent or heat may be used to remove each section of the film to form the holes 50. In other cases, the film may be prepared with holes 50, for example using a mold. As shown in FIG. 7, the holes 50 are arranged in a row. In addition, the hole 50 in the first biocompatible layer 34 aligns with the hole 50 in the second biocompatible layer 35 to provide a pathway for tissue growth through the compressible aid 31. Will be done. Alternatively, the holes 50 may be arranged irregularly. In at least one case, the hole 50 is present in only one of the biocompatible layers 34 and 35.

Referring to FIG. 8, the compressible auxiliary material 51 includes a first biocompatible layer 54 and a second biocompatible layer 55 separated from each other by a plurality of supports or upright struts or fibers 59. The compressible auxiliary material 51 is similar to the compressible auxiliary materials 11 and 31 in many respects. For example, as shown in FIG. 8, the compressible auxiliary material 51 may be arranged with respect to the cartridge deck 16 of the staple cartridge 12. The compressible auxiliary material 51 includes a flat knit double fabric. In certain cases, the compressible aid 51 comprises a set of two knitting fibers configured to produce two tether layers.

The compressible auxiliary material 51 includes a plurality of loops 66 extending in parallel or at least substantially parallel rows. Each loop 66 defines two upright fibers 59 that are located on or start at one of the biocompatible layers 54 and 55 and extend towards the other of the biocompatible layers 54 and 55. The erecting fibers 59 respond to, for example, the proximal direction (P) in response to a compressive force applied to the second biocompatible layer 55 through the tissue (T) disposed with respect to the second biocompatible layer 55. Etc., tilted or skewed to select a cohesive crush in the first direction. Alternatively, the erecting fibers 59 may be tilted or skewed to select a cohesive crush in a second direction opposite to the first direction, such as in the distal direction (D), in response to compressive forces. Alternatively, the compressible aid is tilted or skewed to choose bending in the first direction with the upright fibers 59 of the first group tilted or skewed to choose bending in the first direction. It may include a second group of upright fibers 59 and the like. Various bending directions can bend the compressible auxiliary material 51 in a disjointed manner.

As shown in FIG. 8, the first loop 66a derived from the second biocompatible layer 55 is a first pair extending from the second biocompatible layer 55 toward the first biocompatible layer 54. The upright fiber 59a of the above is defined. The first loop 66a holds a second pair of upright fibers 59b, also defined by a second loop 66b from the second biocompatible layer 55. The second loop 66b is located distal to the first loop 66a. The second pair of upright fibers 59b also extends towards the first biocompatible layer 54. The described pattern is repeated at regular intervals. Similarly, a similar loop 66 from the first biocompatible layer 54 defines a pair of upright fibers 59 extending from the first biocompatible layer 54 towards the second biocompatible layer 55. There is.

The spacing between two consecutive pairs of upright fibers 59 can be increased or decreased to increase or decrease the compressibility of the compressible aid 51, respectively. In general, the fact that a larger number of upright fibers 59 are in a particular section of the compressible auxiliary material 51 corresponds to a higher stability of that section of the compressible auxiliary material 51 under compressive force.

The loops 66 of the first biocompatible layer 54 are arranged in parallel or at least substantially parallel rows 57a, and the loops 66 of the second biocompatible layer 55 are separated from the row 57a. They are arranged in parallel or at least substantially parallel rows 57b.

Referring to FIG. 9, the staple 10030 is fired into the compressible aid 51 and the tissue (T), where the tissue (T) is the first tissue portion 72 having an average tissue thickness (T1). It comprises a second tissue portion 74 having an average tissue thickness (T2) thicker than the tissue thickness (T1). The fired staple 10030 defines a space therein for accommodating the captured compressible aid 51 and the captured tissue (T). The space defined by the fired staple 10030 is at least partially limited by the height (H3) of the fired staple 10030, as shown in FIG. The sum of the final thickness of the captured tissue (T) and the final height of the crushed compressible aid 51 is equal to or at least substantially the height (H3) of the launched staple 10030. Will be equal. In order to compensate for the variation in the thickness of the captured structure (T), the portion of the compressible auxiliary material 51 arranged with respect to the second tissue portion (T2) is the compressible auxiliary material 51. It is compressed to a final height (H2) higher than the final height (H1) of the portion arranged with respect to the first tissue portion (T1) of. This elasticity of the upright fiber 59 allows the compressible aid 51 to be compressed against the second tissue portion 74 to a higher degree than the first tissue portion 72, thereby the compressible aid. The material 51 can compensate for the various thicknesses of the tissue portions 72 and 74 in the space defined by the fired staple 10030. The material composition, porosity, frequency, dimensions, and / or orientation of the upright fiber 59 can be adjusted to control or tune the compressibility of the compressible auxiliary material 51.

Referring to FIGS. 10-12, various compressible aids are arranged with respect to the cartridge deck 16 of the staple cartridge 12. The compressible aids of FIGS. 10-12 are similar to the compressible aids 11, 31, and 51 in many respects. The compressible aids of FIGS. 10-12 are further characterized by connecting nodes or boundaries interconnected by one or more upright fibers. For example, as shown in FIG. 10, the compressible auxiliary material 81 is composed of a first series of binding nodes 84a to 84e defined in the first biocompatibility layer 84 and a first biocompatibility layer 84. It comprises a second series of binding nodes 85a-85e defined within a separated second biocompatible layer 85. Spacers or upright fibers 89 extend from a first series of binding nodes 84a-84e and / or a second series of binding nodes 85a-85e.

The connecting nodes 84a-84e are vertically aligned with, or at least substantially aligned with, the corresponding connecting nodes 85a-85e. Further, the coupling nodes 84a-84e and the coupling nodes 85a-85e are arranged in corresponding columns 102 and 103, respectively, or at least substantially. Although only one row of connecting nodes is shown in each of the biocompatible layers 84 and 85, each of the biocompatible layers 84 and / or 85 may contain multiple rows of connecting nodes or boundaries.

As shown in FIG. 10, the upright fibers 89 may include a first group of upright fibers 89a and a second group of upright fibers 89b interlaced to form a mesh-like structure. The upright fibers 89a generally follow a parallel or at least substantially parallel path inclined or skewed in the proximal direction (P) with respect to the vertical axis. On the other hand, the upright fibers 89b generally follow a parallel or at least substantially parallel path inclined or skewed in the distal direction (D) with respect to the vertical axis.

An angle α is defined between the fibers 89a and 89b extending from the connecting node, for example, the connecting node 85e. The angle α is, for example, any angle within the range of about 10 ° to about 160 °. In certain cases, the angle α is, for example, any angle in the range of about 45 ° to about 135 °. In certain cases, the angle α is, for example, any angle in the range of about 60 ° to about 110 °.

As shown in FIG. 10, the upright fiber 89b extends proximally (P) from the binding node 85a to the binding node 84d. In other words, the upright fiber 89b connects the connecting node at the first position in row 102 with the connecting node at the fourth position in column 103. As a result, the upright fibers 89b intersect four of the upright fibers 89a. In certain cases, the upright fibers 89b may be attached to one or more of the four upright fibers 89a crossed by the upright fibers 89b.

Further, the upright fiber 89a extends distally (P) from the connecting node 85e to the connecting node 84b. In other words, the upright fiber 89a connects the connecting node at the fifth position in row 103 with the connecting node at the second position in row 102. As a result, the upright fibers 89a intersect four of the upright fibers 89b. In certain cases, the upright fibers 89a may be attached to one or more of the four upright fibers 89b crossed by the upright fibers 89a. Crossing the upright fibers 89a and 89b improves the stability of the compressible aid 81 under compressive and / or shear forces.

In certain cases, the orthostatic fiber has a binding node in the first position in the row of binding nodes on the biocompatible layer and a binding node in the second position in the row of connecting nodes on different biocompatible layers. Can extend between and. In certain cases, the orthostatic fiber has a binding node in the first position in the row of binding nodes on the biocompatible layer and a binding node in the third position in the row of connecting nodes on different biocompatible layers. Can extend between and. In certain cases, the orthostatic fiber has a binding node in the first position in the row of binding nodes on the biocompatible layer and a binding node in the fifth position in the row of connecting nodes on different biocompatible layers. Can extend between and. Various bond nodes at various other positions can be connected by the upright fibers 89. In various cases, increasing the distance between interconnected connecting nodes reduces the stiffness of the compressible aid 81.

Referring to FIG. 12, the binding nodes 81 of the biocompatible layer 85 are interconnected via a cross-linking member 92 extending between the binding nodes of the biocompatible layer 85. As shown in FIG. 12, the cross-linking member 92 extends between the coupling nodes 85a and 85b. Another cross-linking member 92 also extends between the coupling nodes 85b and 85c. An additional cross-linking member 92 may extend between various connecting nodes in the same or different rows of the biocompatible layer 85.

In certain cases, at least one of the biocompatible layers 84 and 85 is interconnected via a cross-linking member 92. In certain cases, at least one of the biocompatible layers 84 and 85 is disconnected from each other. As shown in FIG. 10, the binding nodes 84a to 84e of the first biocompatible layer 84 are not directly connected to each other.

Referring to FIG. 12, the compressible auxiliary material 81'is shown. The compressible auxiliary material 81'is similar to the compressible auxiliary material 81 in many respects. In addition, each pair of vertically aligned connecting nodes of the biocompatible layers 84 and 85 are connected by a pair of upright fibers 94. For example, a pair of upright fibers 94 extend between the bond 85a and the bond 84a. The upright fiber 94 improves the stability of the compressible aid 81'under compressive and / or shear forces. In certain cases, only one upright fiber 94 extends between the vertically aligned connecting nodes of the biocompatible layers 84 and 85. In certain cases, three or more upright fibers 94 extend between the vertically aligned connecting nodes of the biocompatible layers 84 and 85.

With reference to FIG. 11, the compressible auxiliary material 100 is shown. The compressible auxiliary material 100 is similar to the compressible auxiliary materials 81 and 81'in many respects. For example, the compressible auxiliary material 100 includes a first biocompatible layer 84'including the binding nodes 84a and 84b and a second biocompatible layer 85'containing the coupled binding nodes 85a and 85b. However, in the first biocompatible layer 84', the binding nodes 84a and 84b of the first biocompatible layer 84'are not vertically aligned with the binding nodes 85a and 85b of the second biocompatible layer 85'. As described above, it is inconsistent with the second biocompatible layer 85'. In an alternative embodiment, however, the binding node of the first biocompatible layer 84'and the corresponding binding node of the second biocompatible layer 85'can be vertically aligned.

As shown in FIG. 11, the discrepancy between the first biocompatible layer 84'and the second biocompatible layer 85' extends between the binding nodes 84a and 84b and the binding nodes 85a and 85b. The upright fibers 94'will be tilted or skewed to select bending in a predetermined direction. For example, in the embodiment shown in FIG. 11, the first biocompatible layer 84'lags behind the second biocompatible layer 85', whereby the binding node 85a is behind, for example, the binding node 84a. Will also precede. As a result, the upright fibers 94'extending between the connecting nodes 85a and 84a choose to bend in the distal direction (D). The erect fibers 94'extending between the connecting nodes 84b and 85b are also skewed or tilted to select bending in the distal direction (D). In an alternative embodiment, the upright fibers 94'can be oriented to choose bending in the proximal direction (P). This pattern is repeated until each pair of upright fibers is parallel to each other or at least substantially parallel to each other. In at least one embodiment, one or more of the standing fibers 94'are oriented to select bending in the proximal direction (P) and one or two of the standing fibers 94'. The above is oriented to select the flexion in the distal direction (D). The bending direction of the upright fibers 94'can be selected at least partially based on the type, position and orientation of the tissue (T) to be treated.

With reference to FIGS. 10 and 12, the outer surfaces of the biocompatible layers 84 and 85 can be adjusted to adapt to various staple cartridge decks and tissue surfaces. For example, as shown in FIGS. 10-12, the connecting nodes or boundaries of the biocompatible layer 84 are not directly connected to each other, thereby providing the flexibility to adapt, for example, to a stepped cartridge deck. It is brought to the biocompatible layer 84. In certain cases, the erecting fibers of the compressible aid may extend beyond the biocompatible layer so as to modify the outer surface of the biocompatible layer.

With reference to FIGS. 13 and 14, the compressible auxiliary material 110 is in many respects similar to the compressible auxiliary materials 11, 31, 51, 81, 81', and 100. For example, the compressible auxiliary material 110 may be arranged with respect to the cartridge deck 16 of the staple cartridge 12. Also, the compressible auxiliary material 110 includes a first biocompatible layer 114, a second biocompatible layer 115, and spacers or upright fibers 119, each of which in many respects is a compressible layer 84, respectively. , The compressible layer 85, and the upright fiber 89.

The upright fiber 119 is configured to structurally support the compressible auxiliary material 110. As shown in FIG. 13, adjacent fiber portions 119a and 119b are configured to intersect each other in order to increase the stability of the compressible aid 110. By applying a compressive force to the compressible aid 110, the fiber portions 119a and 119b can be bent and / or shifted relative to each other.

As shown in FIGS. 13-16, the compressible auxiliary materials 110 and 130 have building blocks 111 arranged on the outer circumference of the compressible auxiliary material 110 and / or, in certain cases, at various other central positions. include. The building block 111 of the compressible auxiliary material 110 has a pair of fiber portions 119a, the pair of fiber portions 119a having a pair of fibers in a plane defined at an intermediate distance between the compressible layers 114 and 115. It is configured to intersect portion 119b. In addition, the four fiber portions 122 define the four corners of the building block 111. Each of the four fiber portions 122 extends, or at least substantially, along the vertical axis that cuts the biocompatible layers 114 and 115. In certain cases, building block 111 does not include vertical fiber portions. Adjacent building blocks 111 share a common fiber portion 122.

As shown in FIG. 13, the intersecting fiber portions 119a and 119b define an angle β, which can be, for example, any angle in the range of about 10 ° to about 170 °. In certain cases, the angle β can be any angle, eg, in the range of about 30 ° to about 100 °. In certain cases, the angle β can be any angle, eg, in the range of about 50 ° to about 70 °.

The upright fibers 119 of the compressible aid 110 further define a gripping mechanism that projects from the first biocompatible layer 114. The gripping mechanism can be in the form of a traction loop 120. As shown in FIG. 13, the two fibrous portions 119a and 119b intersect at a connecting node or boundary 105 on the inner surface 116 of the first biocompatible layer 114 and then of the first biocompatible layer 114. It extends through the first biocompatible layer 114 so as to form a loop 120 over the outer surface 118. Fiber 119 can be passed through the first biocompatible layer 114 to form several loops 120. Alternatively, the loop 120 may be formed on the outer surface 118 independently of the fibers 119. For example, another fiber may be used to form the loop 120 on top of the first biocompatible layer 114. As shown in FIG. 13, the loop 120 is aligned with the connecting node or the boundary 105. Alternatively, in certain cases, loop 120 is not aligned with connecting node 105.

As shown in FIG. 13, the loops 120 are spaced apart and arranged in rows 123. In order to provide traction to the cartridge deck 16 of the staple cartridge 12, the loop 120 is placed on the outer circumference of the biocompatible layer 114 and / or in certain cases various on the first biocompatible layer 114. It can be placed in other positions.

The frequency, position, arrangement, and / or dimensions of the loop 120 in a particular section of the first biocompatible layer 114 will provide the desired degree of traction in that section of the first biocompatible layer 114. Can be controlled to achieve against. For example, if additional traction on the cartridge deck 16 is desired in the proximal portion of the first biocompatible layer 114, then on the proximal portion of the outer surface 118 of the first biocompatible layer 114, the outer surface. More traction loops 120 may be formed compared to the rest of 118.

In addition, the cartridge deck may also include mounting means for holding the traction loop 120 releasably, for example, to improve traction between the compressible aid 110 and the cartridge deck 16. Further, the first biocompatible layer 114 may be designed to include a particularly dense section for thermoforming or joining the cartridge deck 16.

Like the first biocompatible layer 114, the second biocompatible layer 115 may also include a gripping mechanism for exerting traction on the tissue. For example, as shown in FIGS. 15 and 16, the compressible auxiliary material 130 includes a traction loop 140 that is similar to the traction loop 120 in many respects. The traction loop 140 is located on the outer surface 138 of the second biocompatible layer 115. Alternatively, the outer surface 138 of the second biocompatible layer 115 should be smooth or at least substantially smooth and / or minimize internal growth and / or adhesion of tissue. It can be processed.

In various cases, the gripping mechanism of the biocompatible layers 114 and 115, including the loops 120 and 140, may be woven or woven directly onto the biocompatible layers 114 and 115, respectively. In at least one case, the first biocompatible layer 114 and / or the second biocompatible layer 115 is longer in the first direction and more in the second direction intersecting the first direction. It may include satin-type fabrics with short, exposed threads. Satin-type fabrics can increase traction by resisting flow in the second direction. In various cases, the biocompatible layers 114 and 115 can be woven from one or more multifilament fibers, while the upright fibers 119 include monofilament fibers. The monofilament fibers 119 can extend beyond the biocompatible layers 114 and 115 to form loops 120 and 140. The extension of the upright fiber 119 can be looped, for example, in the middle of the knitting pattern of the biocompatible layers 114 and 115.

In various cases, the gripping mechanisms of the biocompatible layers 114 and 115 can be tilted or skewed to improve traction in a given direction, including loops 120 and 140. For example, as shown in FIGS. 15 and 16, the loop 140 is slightly tilted or skewed in the proximal direction (P) to resist the flow of adjacent tissue in the distal direction (D). In an alternative embodiment, the loop 140 may be slightly tilted or skewed in the distal direction (D) to resist the flow of adjacent tissue in the proximal direction (P). In certain cases, some of the loops 140 may be tilted or skewed in the proximal direction (P), and some of the loops 140 may be tilted or skewed in the distal direction (D). good. In various cases, increasing the height of the loop 140 increases the resistance to the flow of adjacent tissues.

With reference to FIGS. 14 and 16, a knife channel or slot 137 is defined within the body of each of the compressible aids 110 and 130. When the compressible aids 110 and 114 are placed relative to the staple cartridge 12, the knife slot 137 is aligned with, or at least substantially substantially aligned with, the knife slot 37 defined within the staple cartridge 12. Knife slots 37 and 137 are configured to accommodate the cutting edge 9116 as it is advanced to cut the tissue captured by the surgical stapler and cutting instrument 8010.

Compressible auxiliary materials such as, for example, compressible auxiliary materials 110 and / or 130 may be manufactured with a knife slot 137. For example, the knife slot 137 can be woven or woven as a locally thin area with reduced fiber density in the body of the compressible aid. Alternatively, the knife slot 137 may be formed in the compressible auxiliary material after manufacture. For example, the knife slot 137 can be cut into the compressible aid using a solvent, heating operation, die cutting operation, laser cutting operation, ultrasonic cutting operation, or a combination of these techniques. Knife slot 137 helps minimize the resistance of the compressible aid to advancing the cutting edge 9116, which in particular improves the life of the cutting edge 9116 and / or provides the cutting edge 9116. The force required to move forward can be reduced.

In certain cases, knife slot 137 may separate the compressible aid into two completely separate parts. Alternatively, as shown in FIGS. 17 and 18, a knife slot 137 extending between the two portions 150a and 150b of the compressible auxiliary material 150 is configured to anchor the two portions 150a and 150b. It can be interrupted by one or more cross-linking members 152. Similar to the compressible aids 110 and 130, each of the sections 150a and 150b of the compressible aid 150 has a first biocompatible layer 114 displaceable with respect to the cartridge deck 16 and with respect to the captured tissue. Includes a second biocompatible layer 115 that can be placed and a spacer or erecting fiber 179 that is similar in many respects to the erecting fiber 119.

Referring to FIGS. 17-19, the upright fiber 179 is configured to structurally support the compressible auxiliary material 150. As shown in FIGS. 17-19, adjacent fiber portions 179a and 179b are configured to intersect each other to increase the stability of the compressible aid 150 under compressive and / or shear forces. There is. By applying a compressive force to the compressible aid 150, the fiber portions 179a and 179b can be bent and / or shifted relative to each other. Similar to the compressible auxiliary material 51 (FIG. 9), the compressible auxiliary material 150 can be adapted to structures having portions of various thicknesses.

Referring to FIG. 19, the biocompatible layers 114 and 115 of the compressible aid 150 extend parallel to or at least substantially parallel to each other. Fiber portions 179a, 179b, and 172 extend between the biocompatible layers 114 and 115 so as to maintain separation between the biocompatible layers 114 and 115. The fiber portions 179a are parallel to each other or at least substantially parallel to each other. The fiber portion 179a extends or at least substantially extends along an axis 171 intersecting the biocompatible layers 114 and 115 at an angle α1. Similarly, the fiber portions 179b are parallel to each other or at least substantially parallel to each other. The fiber portion 179b extends or at least substantially extends along an axis 173 that intersects the biocompatible layers 114 and 115 at an angle α2. In certain cases, the angles α1 and α2 are the same, or at least substantially the same.

The angle α1 can be any angle, for example, in the range of about 10 ° to about 170 °. In certain cases, the angle α1 can be any angle, eg, in the range of about 30 ° to about 100 °. In certain cases, the angle α1 can be any angle, eg, in the range of about 50 ° to about 70 °. Other values for angle α1 are also contemplated in this disclosure.

The angle α2 can be any angle, for example, in the range of about 10 ° to about 170 °. In certain cases, the angle α2 can be any angle, eg, in the range of about 30 ° to about 100 °. In certain cases, the angle α2 can be any angle, eg, in the range of about 50 ° to about 70 °. Other values for angle α2 are also contemplated in this disclosure.

As shown in FIG. 19, the fiber portions 179a and 179b may intersect each other to define multiple "X-shaped" structures. Bonding nodes or boundaries 175 and 178 are defined within the biocompatible layers 115 and 114, respectively, between adjacent X-shaped structures. The ends of the fiber portions 179a and 179b intersect at the connecting nodes 175 and 178. The angle β is defined between the intersecting fiber portions 179a and 179b. The angle β can be any angle, for example, in the range of about 10 ° to about 180 °. In certain cases, the angle β can be any angle, eg, in the range of about 30 ° to about 100 °. In certain cases, the angle β can be any angle, eg, in the range of about 50 ° to about 70 °. In at least one case, the angle β is, for example, equal to or at least substantially equal to the angles α1 and / or the angle α2.

Further, the fiber portion 172, including the fiber portions 172a-172e, extends between the biocompatible layers 114 and 115. The fiber portion 172 is perpendicular to, or at least substantially perpendicular to, the biocompatible layer 114 and the second biocompatible layer 115. As shown in FIG. 19, the fiber portion 172a extends or at least substantially extends along an axis 177 that intersects the biocompatible layers 114 and 115 at an angle α3. The angle α3 can be any angle, for example, in the range of about 80 ° to about 100 °. In certain cases, the angle α3 can be any angle, eg, in the range of about 85 ° to about 95 °. In certain cases, the angle α3 can be any angle, eg, in the range of about 87 ° to about 93 °. Other values of angle α3 are also considered in the present disclosure.

Further, the fiber portions 172 are separated from each other. The fiber portions 172 can be equidistant from each other or arranged in any other suitable configuration. As shown in FIG. 19, the fiber portion 172c passes through the intersection 174 of the X-shaped structure defined by the intersecting fiber portions 179a and 179b. The fiber portion 172d partially passes through the intersection 174 of the X-shaped structure defined by the intersecting fiber portions 179a and 179b. In certain cases, two or more fiber portions 172 may or may not pass through the intersection of an X-shaped structure defined by intersecting fiber portions 179a and 179b. In certain cases, binding nodes or boundaries can be formed at one or more of the intersections 174 by using biocompatible binders, such as biocompatible adhesives.

Referring to FIG. 19, the fiber portion 172b is arranged on one side of the X-shaped structure of the intersecting fiber portions 179a and 179b, and the fiber portion 172b is the intersecting fiber portions 179a and 179b of such an X-shaped structure. It is designed to intersect with. In certain cases, the two or more fiber portions 172 may be similarly arranged with respect to the two or more X-shaped structures as well as the fiber portions 172b.

As shown in FIG. 19, the connecting node 175 is vertically aligned with, or at least substantially aligned with, the connecting node 178. In certain cases, the fiber portion 172, for example the fiber portion 172e, may extend between the vertically aligned bond nodes 175 and 178.

With reference to FIGS. 17 and 18, the cross-linking member 152 is cut by the cutting edge 9116 while the cutting edge 9116 is advanced to cut the tissue captured by the surgical stapler and cutting instrument 8010. To. Alternatively, one or more of the cross-linking members 152 may be located outside the path of the cutting edge 9116 and will continue after the surgical stapler and cutting instrument 8010 has been fired. The portions 150a and 150b may be stapled together.

Referring to FIGS. 20 to 22, the portions 150a and 150b of the compressible auxiliary material 160 are joined by the cross-linking member 162. As shown in FIG. 20, the cross-linking member 162 is separated along the length of the knife slot 137 to provide a separate mounting means between the portions 150a and 150b. One or more of the cross-linking members 162 are cut by the cutting edge 9116 as the cutting edge 9116 is advanced to cut the tissue captured by the surgical stapler and cutting instrument 8010. Can be done.

As shown in FIGS. 21 and 22, the cross-linking member 162 is also configured to attach or anchor the compressible auxiliary material 160 to the staple cartridge 12. The section of the cross-linking member 162 extends through a notch or hole 164 in the bottom portion 17 of the staple cartridge 12 so as to secure the compressible auxiliary material 160 to the staple cartridge 12. The cross-linking member 162 may also be passed through knife slots 37 and 137. The cross-linking member 162 is provided with a portion 150a by shearing or cutting motion resulting from the passage of the cutting edge 9116 as the cutting edge 9116 is advanced to cut the tissue captured by the surgical stapler and cutting instrument 8010. And 150b can be cut from each other and / or to release from the staple cartridge 12.

As shown in FIGS. 21 and 22, the notches 164 are formed at separate positions on both sides of the knife slot 37 of the staple cartridge 12. In certain cases, the cross-linking member 162 is in the form of a suture that is pierced through a notch 164, for example, to attach the compressible aid 160 to the staple cartridge 12. In certain cases, the notch 164 can be replaced or used in combination with a protrusion extending from the bottom portion 17 of the staple cartridge 12. The protrusion may be configured to hold a section of the cross-linking member 162 for attaching the compressible aid 160 to the staple cartridge 12. Other mounting means may be formed on the staple cartridge 12 to facilitate the attachment of the compressible aid 160 to the staple cartridge 12 by the cross-linking member 162.

With reference to FIG. 23, the crosslinked sheath 182 may extend between the two portions of the compressible auxiliary material 180. In FIG. 23, the crosslinked sheath 182 is cut by a cutting edge 9116. Only one portion 150a of the compressible auxiliary material 180 is shown. Also, the portion of the cut crosslinked sheath 182 that is still attached to the portion 150a of the compressible auxiliary material 180 is shown. The cutting edge 9116 is advanced through the knife slots 37 and 137 along the path defined by the longitudinal axis AA to cut the crosslinked sheath 182.

In certain cases, as shown in FIG. 23, the crosslinked sheath 182 is defined between the bottom portions of the knife slot 137 of the compressible auxiliary material 180. In such cases, the crosslinked sheath 182 may be part of a first biocompatible layer 114 extending between the two portions of the compressible auxiliary material 180. Further, in such a case, when the compressible auxiliary material 180 is arranged with respect to the cartridge deck 16 of the staple cartridge 12, the cross-linking sheath 182 has a knife slot 137 of the compressible auxiliary material 180 and a knife slot of the staple cartridge 12. Separate from 37, or at least partially.

In another example, the crosslinked sheath 182 is defined between the top surface portions of the knife slot 137 of the compressible auxiliary material 180 of the compressible auxiliary material 180. In such cases, the crosslinked sheath 182 can be part of a second biocompatible layer 115 that extends between the two portions of the compressible aid 180. Further, in such a case, when the compressible auxiliary material 180 is arranged with respect to the cartridge deck 16 of the staple cartridge 12, the cross-linking sheath 182 inserts the knife slot 137 of the compressible auxiliary material 180 into the knife slot of the staple cartridge 12. Does not separate from 37. Instead, knife slots 137 and 37 are located below the cross-linking sheath 182. In yet another example, the crosslinked sheath 182 is of the compressible auxiliary material 180, for example, through a plane defined between the biocompatible layers 114 and 115 of the compressible auxiliary material 180, or at least substantially through. Can extend between parts.

Referring again to FIG. 23, the compressible auxiliary material 180 may be attached to the staple cartridge 16 by anchoring the crosslinked sheath 182 to the bottom portion 17 of the staple cartridge 16. For example, attachment means such as sutures may be passed through the cross-linking sheath 182 and the notch 164 to secure the cross-linking sheath 182 to the bottom portion of the staple cartridge 12. The suture can be cut, for example, by the cutting edge 9116 in order to gradually release the compressible aid 180 from the staple cartridge 12. By attaching the compressible auxiliary material 180 to the staple cartridge 16 by passing the suture thread only through the crosslinked sheath 182 at the bottom surface of the knife slot 137, the rest of the compressible auxiliary material 180 can be freely left without losing the attachment tension of the suture thread. It is compressed. The same can be achieved, for example, by threading the suture only through the first biocompatible layer 114.

Referring to FIGS. 24 and 25, the compressible auxiliary material 190 is arranged with respect to the cartridge deck 16 of the staple cartridge 12. The compressible auxiliary material 190 is similar to the compressible auxiliary materials 11, 31, 51, 81, 81', 100, 110, 130, 150, and / or 180 in many respects. For example, the compressible auxiliary material 190 includes a first biocompatible layer 114, a second biocompatible layer 115, and a spacer or upright fiber 199 extending between the biocompatible layers 114 and 115. ..

As shown in FIG. 24, the compressible auxiliary material 190 is fixed to the staple cartridge 12 by a fixing member 191 which includes a bendable spine or protrusion 192 protruding from an elongated support member 194. The bendable protrusion 192 penetrates into the structure relatively easily, but is removed from the structure until sufficient force is applied to bend the bendable protrusion 192 away from the elongated support member 194. Is shaped like an arrowhead configured to resist.

The bendable protrusions 192 are arranged at the end portions 195 and 196 on both sides of the elongated support member 194. In at least one example, as shown in FIG. 24, three flexible protrusions 192 are arranged on each of the termination portions 195 and 196 on either side. The bendable protrusions 192 of the end portions 195 and 196 on both sides are spaced equal apart from each other. More than three or fewer bendable protrusions 192 may be placed on each of the terminations 195 and 196 on either side. Other configurations of bendable protrusions 192 with respect to the elongated support member 194 are also contemplated in the present disclosure.

Referring to FIG. 24, two fixing members 191 are used to secure at least a portion of the compressible cartridge 190 to the staple cartridge 12. More than two or fewer fixing members 191 may be used to secure the compressible cartridge 190 to the staple cartridge 12. As shown in FIG. 24, the termination portion 195 of the fixing member 191 is inserted through the biocompatible layer 114, while the termination portion 196 is inserted into the staple cavity 197 of the staple cartridge 12 through the cartridge deck 16. .. Staples 10030 are located within the staple cavities 197. Deployment of staples 10030 from staple cavities 197 is blocked by, or at least partially blocked, by the termination portion 196. When the staple 10030 is deployed from the staple cavity 197, the staple 10030 pushes the termination portion 196 out of the staple cavity 197 to release the fixing member 191 from the staple cartridge 12.

The termination portion 196 of the other fixing member 191 may be gradually released from the other staple cavities 197 of the staple cartridge 12 during the deployment of each staple 10030. Since the staples 10030 are gradually released from their respective staple cavities 197 by advancing the wedge threads 9126 (FIG. 4), the compressible auxiliary material 190 is gradually released correspondingly, which is also a surgical staple fastening. And achieved by advancing the wedge threads 9126 during the firing sequence of the cutting instrument 8010. In essence, the fixation member 191 with the termination portion 196 inserted into the more proximal staple cavity is more than the fixation member 191 with the termination portion 196 inserted into the more distal staple cavity. Released before.

By gradually releasing the compressible auxiliary material 190, the relative arrangement between the compressible auxiliary material 190 and the staple cartridge 12 at individual positions on the cartridge deck 16 is such that the staples 10030 at such positions are respectively. It is maintained until it is fired from the staple cavity 197 of. The fixation member 191 also resists the accumulation of compressible aid 190 that may occur when the cutting edge 9116 is advanced during the firing sequence of the surgical stapler and cutting instrument 8010.

Referring to FIG. 24, the fixing members 191 in the staple cavity 197 extend parallel to each other or at least substantially parallel to each other. In at least one case, the fixing members 191 in the staple cavity 197 may, for example, intersect each other to define an "X" shape.

With reference to FIG. 24, the outermost bendable protrusions 192 at each of the terminations 195 and 196 on either side of the elongated support member 194 may define a perforated tip for penetrating the structure. The perforated tip can be specially hardened to facilitate penetration into the structure. Further, the arrowhead shape of the bendable protrusion 192 can improve the stability of adhesion between the fixing member 191 and the compressible auxiliary material 190, for example, by the entanglement of the bendable protrusion 192 and the upright fiber 199.

Referring to FIG. 25, the terminal portion 196 of the elongated support member 194 of the fixing member 191 is inserted into the staple cavity 197 of the staple cartridge 12. The end portion 196 is an elongated support portion 192a protruding from the elongated support member 194 at the first side portion of the elongated support member 194 and an elongated support portion 194 at the second side portion of the elongated support member 194 opposite to the first side portion. Includes four bendable protrusions 192 that define the attachment portion 192b protruding from the member 194. The attachment portion 192a defines an angle α1 with respect to the elongated support member 194 on the first side portion, whereas the attachment portion 192b defines an angle α2 with respect to the elongated support member 194 on the second side portion. ing.

In certain cases, the angle α1 and / or the angle α2 can be any angle, eg, in the range of about 1 ° to about 90 °. In certain cases, the angle α1 and the angle α2 can be any angle, eg, in the range of about 30 ° to about 70 °. In certain cases, the angle α1 and / or the angle α2 can be any angle, eg, in the range of about 40 ° to about 60 °. In at least one case, the angle α1 is equal to, or at least substantially equal to, the angle α2. In at least one case, the angle α1 is different from the angle α2.

As shown in FIG. 25, the bendable protrusions 192 include attachment portions 192a and 192b extending from the same position on the elongated support member 194, respectively. Alternatively, the bendable protrusion 192 may include only one of the attachment portions 192a and 192b. In at least one case, the attachment portions 192a and 192b of the bendable protrusions 192 are made from biocompatible fibers extending from the elongated support member 194. In at least one case, the elongated support member 194 can also be made from biocompatible fibers.

In various cases, the edges of the compressible auxiliary material may be configured to improve the adhesion of the staple cartridge 12 to the cartridge deck 16 and / or improve the structural performance of the compressible auxiliary material. For example, as shown in FIG. 17, the edges 151a and 151b of the parts 150a and 150b of the compressible auxiliary material 150 are formed into outer lips 153 defining the outer circumference of the compressible auxiliary material 150, respectively, and the cartridge deck 16 is formed. Can be attached to.

In certain cases, the outer lip may be formed after the manufacture of the compressible aid. For example, the outer circumference of the biocompatible layer of the compressible aid may be subject to heat and / or pressure to form the outer lip. In certain cases, the outer lip can be formed, for example, by weaving or braiding the outer circumference of the biocompatible layer of the compressible aid into an integral structure defining the outer lip. As shown in FIG. 26, the outer lip 203 of the compressible auxiliary material 200 has an integral structure defining the outer peripheral 217 and 218 of the biocompatible layers 114 and 115 of the compressible auxiliary material 200, respectively, to define the outer lip 203. It is formed by knitting with.

Integrating the perimeter of the biocompatible layer of the compressible aid can help stabilize the compressible aid and / or minimize shear crushing during compression. In certain cases, however, the biocompatibility of the compressible auxiliary material to minimize structural and / or other differences between the outer circumference and the center of the compressible auxiliary material that may result from this improvement. It is desirable to maintain the spacing between the outer perimeters of the layers.

Referring to FIG. 27, the tapered edge 212 is defined by the compressible auxiliary material 210. The compressible auxiliary material 210 includes a first biocompatible layer 214, which extends laterally beyond the second biocompatible layer 215. Alternatively, the compressible auxiliary material 210 may include a second biocompatible layer 215, the second biocompatible layer 214 extending laterally beyond the first biocompatible layer 214.

The biocompatible layers 214 and 215 are in many respects similar to the biocompatible layers 114 and 115. For example, the first biocompatible layer 214 is configured to be located and / or adhered to the cartridge deck 16 with respect to the cartridge deck 16, and the second biocompatible layer 215 is an anvil 8014 and a staple cartridge. It is configured to be placed for the tissue captured between the twelve. In at least one case, the tapered edge 212 of the compressible auxiliary material 210 is formed by removing or cutting off a portion of the compressible auxiliary material 210. The cut plane can be formed at a predetermined angle based on the desired sharpness of the tapered edge 212.

With reference to FIGS. 28-30, the compressible auxiliary material 230 is shown. The compressible auxiliary material 230 is similar to the other compressible auxiliary materials described in the present disclosure. For example, similar to the compressible auxiliary material 51 (FIG. 9), the compressible auxiliary material 230 can compensate for variations in the thickness of the structure (T) captured together with the compressible auxiliary material 230 by the staples 10030. As shown in FIG. 28, the compressible auxiliary material 230 has a structure having tissue portions 72 and 74 having various tissue thicknesses when the tissue portions 72 and 74 are captured together with the compressible auxiliary material 230 by staples 10030. It is configured to adapt to T).

Referring to FIG. 28, the compressible auxiliary material 230 includes a plurality of structural cells 236 disposed between the cartridge contact surface 234 and the tissue contact surface 235. One or more of the structural cells 236 may extend longitudinally along or at least substantially along the entire length of the compressible auxiliary material 230. The structural cell 236 is generally surrounded by a wall defining an outer circumference on the structural cell 236. Adjacent structural cells 236 may share one or more walls.

Referring to FIG. 29, the structural cell 236 is defined by six walls and has a hexagonal shape. In at least one case, one or more of the structural cells 236 may include three or four or more walls, respectively. The structural cells 236 of the compressible auxiliary material 230 may include the same number of walls. For example, alternatively, the first group of structural cells 236 may contain a first number of walls, while the second group of structural cells 236 may have a second number of walls that is different from the number of first walls. Can include walls. In at least one case, the structural cell 236 defines a honeycomb shape that extends longitudinally along at least a portion of the total length of the compressible auxiliary material 230, or at least substantially along.

This honeycomb shape improves the stability of the compressible auxiliary material 230 under compressive and / or shear forces. In addition, honeycomb-shaped structural cells 236 are placed against the compressible aid 230 and the second biocompatible layer 215 as the anvil 8014 is moved to the closed position opposite to the staple cartridge 12. It can be bent under the compressive force applied to the formed structure (T). As shown in FIGS. 29 and 30, the honeycomb-shaped structural cell 236 is configured to undergo a reduction in height when compressive forces are applied to the compressible aid 230, whereby FIG. 28. As shown in, the compressible auxiliary material 230 has a structure having the tissue portions 72 and 74 when the tissue portions 72 and 74 having various tissue thicknesses are captured together with the compressible auxiliary material 230 by the staple 10030 (T). ) Can be adapted.

Referring to FIGS. 29 and 30, structural cell 236 responds to the compressive force applied to the compressible aid 230 as the anvil 8014 is moved to the closed position opposite to the staple cartridge 12, as shown in FIG. 29. The height is reduced from the first height (H1) as shown to the second height (H2) as shown in FIG. This reduction in height may correspond to the thickness of the captured structure (T) placed relative to the compressible aid 230 in which the structural cells 236 are located. In other words, as the thickness of the tissue portion increases, so does the reduction in height of the structural cell 236 located on a portion of the compressible aid 230 disposed with respect to the tissue portion.

The ratio of the second height (H2) to the first height (H1) can be, for example, any value from about 0.05 to about 0.95. In certain cases, the ratio of the second height (H2) to the first height (H1) can be, for example, any value from about 0.2 to about 0.7. In certain cases, the ratio of the second height (H2) to the first height (H1) can be, for example, any value from about 0.3 to about 0.6. Other values of the ratio of the second height (H2) to the first height (H1) are also contemplated by the present disclosure.

The walls of structural cells 236 may have the same or at least substantially the same thickness. Alternatively, as shown in FIG. 29, the walls of the structural cell 236 may have varying thicknesses. The pair of facing walls 242 may have a first thickness (T1), the pair of facing walls 244 may have a second thickness (T2), and the pair of facing walls 246 may have a third. It may comprise a thickness (T3), where at least two of a first thickness (T1), a second thickness (T2), and / or a third thickness (T3) are relative to each other. It's different. For example, as shown in FIG. 29, the first thickness (T1) of the wall 242 is thicker than the second thickness (T2) of the wall 244 and more than the third thickness (T3) of the wall 246. thick.

Referring to FIGS. 28-30, the wall 242 of the structural cell 236 extends parallel or at least substantially parallel to the first biocompatible layer 234 and the second biocompatible layer 235. In certain cases, the wall 242 of the structural cell 236 may define a portion of the first biocompatible layer 234. In certain cases, the wall 242 of the structural cell 236 may define a portion of the second biocompatible layer 235.

As shown in FIG. 28, the building block of the compressible auxiliary material 230 includes five structural cells 236, including a central structural cell 236 that shares a wall with the other four structural cells 236. The height (H) of the compressible auxiliary material 230 may be defined by the stacking of two structural cells 236 sharing the wall 244, as shown in FIG. Alternatively, the height (H) of the compressible auxiliary material 230 is such that, as shown in FIG. 29, two four-walled structural cells 237 and one structural cell 236 extending between those structural cells 237. Can be defined by stacking. Structural cells 236 share a wall 242 with each of structural cells 237. Other geometric shapes and arrangements of the structural wall of the compressible aid 230 are also contemplated by the present disclosure.

Various attachments may be anchored or secured to the compressible aids of the present disclosure. Attachments can be made from the same or at least substantially the same material as the compressible aid. Alternatively, the attachment can be made from a different material than the compressible aid. In at least one case, the attachment may be made from the same material as the compressible auxiliary material, which may, for example, improve one or more of the chemical and / or physical properties of the attachment. Therefore, it is processed separately.

In at least one case, the compressible auxiliary material can be harder or softer than the attachment fixed to the compressible auxiliary material. The stiffer attachment may provide the desired stiffness for fixing the attachment to the cartridge deck, for example. Alternatively, softer attachments can result in, for example, more delicate interactions with sensitive tissues. In at least one case, the compressible auxiliary material may have a smoother or rougher surface than the surface of the attachment fixed to the compressible auxiliary material. Ultimately, the attachment can be adjusted to perform various functions with the compressible aid. In various cases, the attachment can be in the form of a side attachment or end cap for a compressible aid.

Referring to FIGS. 28-30, the side attachment 250 is fixed or fixed to the compressible auxiliary material 230. In at least one case, the side attachment 250 may be secured to the compressible aid 230, for example by thermal or solvent welding. The side attachment 250 defines a tapered edge 252 of the compressible aid 230.

Further, the side attachment 250 can be used, for example, to attach the compressible auxiliary material 230 to the cartridge deck 16 of the staple cartridge 12. In at least one case, the side attachment 250 can be welded onto the cartridge deck 16 by using, for example, heat or a solvent. Other techniques for fixing the side attachment 250 to the compressible aid 230 and / or to the cartridge deck 16 are also contemplated by the present disclosure. For example, the tether 254 of the side attachment 250 (FIG. 29) may be fixed to and / or wrapped around the staple cartridge 12.

Compressible aids and / or side attachments may be configured to promote internal growth of the tissue. For example, as shown in FIGS. 28-30, the compressible auxiliary material 230 and the side attachment 250 have holes 254 configured to promote the internal growth of tissue into the compressible auxiliary material 230 and the side attachment 250. include. The holes 254 may be selectively formed through the compressible aid 230 and / or the side attachment 250 in areas where internal growth of the tissue is desired.

In various cases, the compressible auxiliary material 230 and / or the side attachment 250 may be manufactured, for example, by various extrusion techniques, and the hole 254 may be, for example, the desired portion of the compressible auxiliary material 230 and / or the side attachment 250. Can be laser perforated inside. The side attachment 250 may be attached to the compressible auxiliary material 230, for example, after extrusion. Adjusted compressive resistance can be achieved in the compressible auxiliary material 230, for example, by making the walls of structural cells, such as structural cells 236, to a predetermined thickness. For example, to adjust the flexibility of the structural cells in the compressible auxiliary material 230 to achieve the desired stiffness regardless of the material used in the manufacture of the compressible auxiliary material 230, a non-uniform wall thickness. Pattern can be extruded.

With reference to FIG. 31, the compressible auxiliary material 260 is shown. The compressible auxiliary material 260 includes a first biocompatible layer 114 disposed with respect to the cartridge deck 16 of the staple cartridge 12. In addition, the compressible auxiliary material 260 includes a second biocompatible layer 115 that can be placed with respect to the tissue (T). A plurality of upright walls or spacer walls 262 are defined between the biocompatible layers 114 and 115. The upright wall 262 is configured to maintain the space between the biocompatible layers 114 and 115, as shown in FIG. In addition, the upright wall 262 is a tissue placed against the compressible aid 260 and the second biocompatible layer 115 as the anvil 8014 is moved to the closed position opposite to the staple cartridge 12. It can be bent under the compressive force applied to (T).

The upright wall 262 is attached to the biocompatible layers 114 and 115 and is separated from each other. Alternatively, the upright walls 262 can be anchored or attached to each other. Some of the upright walls 262 are arranged parallel to each other or at least substantially parallel to each other. However, another upright wall 262 extends into the intersecting plane.

Further, the upright wall 262 is provided with a cutout or gap 264 that improves the flexibility of the upright wall 262. In at least one case, one or more of the upright walls 262 can be made with a cutout 264, for example by extrusion. Alternatively, the cutout 264 may be formed after the upright wall 262 has been made. The cutout 264 may be systematically arranged, for example, to achieve the desired flexibility of the compressible auxiliary material 260.

Referring to FIG. 32, the compressible auxiliary material 270 includes a first biocompatible layer 114 disposed with respect to the cartridge deck 16 of the staple cartridge 12. The compressible auxiliary material 270 lacks a second biocompatible layer. Therefore, the structure (T) is placed directly with respect to the plurality of spacers or upright walls 272 of the compressible auxiliary material 270. Alternatively, the compressible aid 270 may include a second biocompatible layer on the opposite side of the upright wall 272. In such cases, the tissue (T) may be placed relative to the second biocompatible layer. In addition, the upright wall 272 is in addition to the compressible auxiliary material 270 and the structure (T) placed against the upright wall 272 when the anvil 8014 is moved to the closed position opposite to the staple cartridge 12. It can be bent under the compressive force.

The upright wall 272 includes a vertical wall 272a and a horizontal wall 272b that intersects the vertical wall 272a. The upright wall 272 comprises a hollow or at least substantially hollow frame, as shown in FIG. Alternatively, the upright wall 272 may include a solid frame. In various cases, the upright wall 272 comprises, for example, the shape of a triangular prism. The upright wall 272 comprises a triangular cross-sectional area. The upright wall 272 may include, or instead of, a triangular cross-section region having a square shape, a rectangle, and / or a curvilinear cross-section region. As shown in FIG. 32, the vertical wall 272a has a triangular vertical cross-sectional area, and the horizontal wall 272b has a triangular vertical cross-sectional area.

The vertical wall 272a has a base 276a defined by the first biocompatible layer 114 and a vertex 274a extending longitudinally parallel to or at least substantially parallel to the other vertices 274a of the adjacent vertical wall 272a. I have. The transverse wall 272b also comprises a base 276b defined by a first biocompatible layer 114 and a vertex 274b extending laterally parallel to or at least substantially parallel to the other vertices 274b of the adjacent lateral wall 272b. ing.

As shown in FIG. 32, the compressible auxiliary material 272 includes a structural cell 278 with a transposed pyramid shape. Structural cells 278 are defined between two parallel or at least substantially parallel walls 272a and two parallel or at least substantially parallel walls 272b intersecting the wall 272a. The bottom 280 of the structural cell 278 comprises four corners 282 defined by intersecting walls 272a and 272b. The apex 284 of the structural cell 278 is defined in the first biocompatible layer 114. Each structural cell 278 extends from apex 284 and terminates at a base 280, as shown in FIG.

In various cases, the second biocompatible layer of the compressible auxiliary material of the present disclosure, such as, for example, the second biocompatible layer 115 of the compressible auxiliary material 110, has the compressible auxiliary material 110 of the staple cartridge 12. It is visible when placed relative to the cartridge deck 16. In various cases, specific information may be communicated to the operator through images, words, symbols, and / or colors woven or printed onto a second biocompatibility layer. For example, a braid can be used to indicate the moving length of the knife, which can help the operator reduce the number of loads used in the procedure. Braids can also be used to indicate the location of staple crowns. In addition, braids can also be used to provide information about staple cartridges used with compressible aids, such as staple heights. In addition, braids can also be used to delineate optimal positions for placing the tissue to be treated relative to the compressible aid.

A staple cartridge assembly containing the embeddable layer 4000 is shown in FIG. The staple cartridge assembly further comprises a cartridge body 12 that includes a deck 16 that supports layer 4000. Layer 4000 comprises a bottom portion 4004 supported by the deck 16 and, in addition, a top portion 4005. The bottom portion 4004 and the top portion 4005 are connected by a wall 4009. Although the wall 4009 extends laterally beyond the layer 4000, the wall 4009 may extend in any suitable direction, for example in the longitudinal direction. In at least one embodiment, the cartridge body 12 comprises a longitudinal slot configured to receive the cutting member, and the wall 4009 extends throughout the longitudinal slot.

Wall 4009 defines chamber 4008 between them. When a load is applied to layer 4000, chamber 4008 bends, flexes, and / or crushes wall 4009. The amount of bending of the wall 4009 depends on the thickness of the tissue pressed against the layer 4000. When the tissue is pressed downwards onto the layer 4000, the layer 4000 may adapt to the thickness of the tissue being pressed against the layer 4000. In other words, layer 4000 can provide local adaptation to local variations in tissue thickness, as shown in FIG. 34. In various cases, the wall 4009 defines a seam in layer 4000. The seams can be, for example, lateral seams and / or longitudinal seams. The arrangement of seams can control the flexure of layer 4000.

In addition to the above, layer 4000 includes structural fibers 4006 and reinforcing fibers 4007. Structural fibers 4006 are arranged to form a bottom portion 4004, a top portion 4005, and a wall 4009. In at least one case, as shown in FIG. 33, the structural fibers 4006 are arranged in a longitudinal row with longitudinal seams in between. Structural fibers 4006 extend between the bottom portion 4004 and the top portion 4005 to form columns or columns connecting them. Reinforcing fibers 4007 are woven in a bottom portion 4004, a top portion 4005, and / or a wall 4009. In at least one case, the reinforcing fibers 4007 are tied, looped and / or wound around the structural fibers 4006. In various cases, the reinforcing fiber 4007 is combined with the structural fiber 4006.

Reinforcing fibers 4007 connect structural fibers 4006 in the wall 4009. Reinforcing fibers 4007 hold or bind the stanchions within the wall 4009 to each other so as to give the wall 4009 the desired structural properties. For example, wall 4009 with higher density reinforcing fibers 4007 is stronger than wall 4009 with lower density. Similarly, the density of the reinforcing fibers 4007 in the bottom portion 4004 and / or the top portion 4006 can affect the strength of the portions 4004 and / or 4006.

As a result of the above, the structural struts in the wall 4009 can bend and move with each other. Further, the structural fiber struts 4006 in the wall 4009 are supported by the adjacent structural fiber struts 2006 by the reinforcing fibers 4007. As shown in FIG. 33, the reinforcing fibers 4007 in one wall 4009 are not directly connected to the reinforcing fibers 4007 in the adjacent wall 4009, but the reinforcing fibers 4007 in the first wall 4009 are. It may be connected to the reinforcing fibers 4007 in the second wall 4009 via the bottom portion 4004 and / or the top portion 4006. In various alternative embodiments, the reinforcing fibers 4007 can spread directly between adjacent walls 4009 and connect them.

Structural fibers 4006 and reinforcing fibers 4007 can adhere to each other at the nodule boundaries. Nodule boundaries may include any suitable nodule type. The type of nodule boundary used can affect the stiffness of layer 4000. For example, if loose nodules are used, the layer 4000 may be less rigid or have a lower modulus. Alternatively, if a rigid nodule is used, the layer 4000 may be more rigid or have a higher modulus of elasticity. Layer 4000 may utilize any suitable type of nodule.

In addition to the above, the knots between the structural fibers 4006 and the reinforcing fibers 4007 can be utilized to selectively impart different stiffness or modulus to different parts of the layer 4000. For example, the type of nodule and / or the frequency of the nodule between the structural fiber 4006 and the reinforcing fiber 4007 may be selected to produce a first compression zone and a second compression zone. The first compression zone has a first rigidity, and the second compression zone has a second rigidity higher than the first rigidity. In at least one case, the first compression zone is aligned with and placed on the longitudinal slots defined within the deck 12, configured to receive the cutting member, and the second. The compression zone of is aligned with the staple cavities defined in the deck 12 and is located above the staple cavities. Such an arrangement may provide the desired tissue thickness compensating property within the staple 10030 that captures the layer 4000 against the tissue while facilitating the cleavage of the layer 4000. In certain cases, the first compression zone is aligned with the proximal end of the deck 12, and the second compression zone is located distal to the first compression zone. In at least one such case, another first compression zone is located distal to the second compression zone. Such an arrangement may facilitate cutting of layer 4000 at the beginning and end of the cutting process of the cutting member.

The structural fiber 4006 has a first cross-sectional width or diameter, and the reinforcing fiber 4007 has a second cross-sectional width or diameter different from the first cross-sectional width. As shown in FIGS. 33 and 34, the cross-sectional width of the structural fiber 4006 is wider than the cross-sectional width of the reinforcing fiber 4007. In at least one case, for example, the cross-sectional width of the structural fiber 4006 is about twice the cross-sectional width of the reinforcing fiber 4007.

The structural fiber 4006 is composed of a first material, and the reinforcing fiber 4007 is composed of a second material different from the first material. In at least one case, the structural fiber 4006 is composed of a first polymer material and the reinforcing fiber 4007 is composed of a second polymer material having a modulus lower than that of the first polymer material. To. In an alternative embodiment, the structural fiber 4006 is composed of a first polymer material and the reinforcing fiber 4007 is composed of a second polymer material having a modulus higher than that of the first polymer material. Will be done. In certain embodiments, the structural fiber 4006 is composed of one or more polymeric materials and / or the reinforcing fiber 4007 is composed of one or more polymeric materials. In at least one such embodiment, the structural fibers 4006 and the reinforcing fibers 4007 have at least one material in common with each other and at least one material not in common.

Referring here to FIG. 35, the implantable layer 4100 comprises a top portion 4105 and a strut wall 4109 supporting the top portion 4105. The top portion 4105 comprises a longitudinal structure or fiber 4103 interconnected by a structural fiber 4106 comprising a strut wall 4109. Structural fibers 4106 are looped, wound and / or knitted around longitudinal fibers 4103 in any suitable manner. 38A and 38B disclose two exemplary schemes in which structural fibers 4106 are interconnected to longitudinal fibers 4103.

In addition to the above, FIG. 38A shows a double loop type winding. The structural fiber 4106 is wound around the first warp fiber 4103, crosslinked to the second warp fiber 4103, and wound around the second warp fiber 4103. The double loop type structural fiber 4106 comprises two upright ends with legs or struts that are part of the stanchion wall 4109. Both loops of the structural fiber 4106 include a closed loop and / or at least one turn, but envision an alternative embodiment in which each loop comprises a round turn and / or a plurality of turns centered on the longitudinal fiber 4103. Will be done. The double loop type winding of FIG. 38A may also be referred to as an inner double loop. More specifically, each of the struts of the structural fibers 4106 passes through a gap defined between adjacent first and second longitudinal fibers 4103. Outer double loops may be utilized in various embodiments.

In addition to the above, FIGS. 38B and 39 show structural fibers 4106 wrapped around the first warp fibers 4103, crosslinked to the second warp fibers 4103, and wrapped around the second warp fibers 4103. ing. Wrapping around the first longitudinal fiber 4103 involves an open loop, but for example a closed loop and / or younger one or more turns may also be utilized. Wrapping around the second longitudinal fiber 4103 involves turns, but round turns may also be utilized, for example. Similar to the above, the structural fiber 4106 of FIG. 38B comprises two upright ends with legs or struts that are part of the stanchion wall 4109. The upright ends of the structural fibers 4106 extend through various gaps between the warp fibers 4103.

Referring here to FIGS. 36 and 37, layer 4200 comprises a vertical structure or fiber 4103. Layer 4200 further comprises structural fibers 4206 and reinforcing fibers 4107. Reinforcing fibers 4107 are laterally woven within the warp fibers 4103. Structural fibers 4206 are wound around a plurality of warp fibers 4013 so as to form a wall 4209. As shown, each structural fiber 4206 is wound around four warp fibers 4103, eg, to form a wall 4209. As a result of the above, each structural fiber 4206 forms several closed loop struts that support the top portion 4205 of layer 4200. Although the ends of the structural fibers 4206 do not support the top portion 4205, alternative embodiments are also contemplated in which the ends of the structural fibers 4206 constitute structural struts.

The embodiments disclosed herein are organized fiber scaffolds with compression and bending properties that are interwoven with another scaffold in a manner that forms a larger matrix with compression and bending properties in multiple directions. Can be provided. Such compression and bending properties can be adjusted by adjusting one or more of the features disclosed herein. The walls of the matrix can define the arrangement of macrovoids. In various cases, the matrix can be bimodal with macrovoids defined between the walls in the matrix and the gaps defined between the fibers that make up the walls. Such macrovoids and interstices can cooperate to promote internal growth of tissue and matrix accumulation in the body.

FIG. 40 shows a tissue thickness compensator or compressible auxiliary material 2000. The compressible auxiliary material 2000 can be used with a large number of devices. In at least one embodiment, the compressible aid 2000 can be used with a surgical stapler and cutting instrument 8010. The compressible auxiliary material 2000 may be attached to the staple cartridge deck 16 of the staple cartridge. Alternatively, in certain embodiments, the compressible auxiliary material 2000 may be attached to the anvil 8014.

Referring to FIG. 40, the compressible auxiliary material 2000 is shown, in at least one embodiment, partially compressed by the tissue T. The staple 2002 is similar to the staple 10030 in many respects and engages the compressible aid 2000 as the staple 2002 is fired and molded by the surgical staple fastening and cutting instrument 8010. The molded staple 2002 has a staple base 2004, a first staple leg 2006, and a second staple leg 2008. In this embodiment, the first staple leg 2006 engages the tissue T and the compressible aid 2000.

The compressible auxiliary material 2000 includes a first portion 2012 having a tissue contact interface 2010. When the compressible aid 2000 is engaged by the tissue T, the tissue contact interface 2010 contacts and interacts with the tissue T. The compressible auxiliary material 2000 includes a second portion 2016 having a cartridge interface 2014. In this embodiment, the cartridge interface 2014 may be releasably attached or placed on or adjacent to the staple cartridge deck 16.

The compressible auxiliary material 2000 includes a central portion disposed between the first portion 2012 and the second portion 2016. The central portion comprises a plurality of upright fiber struts 2018 and a plurality of interconnect fibers 2024. The upright fiber strut 2018 engages with the first portion 2012 at the first portion / upright fiber strut interface 2020. The upright fiber strut 2018 engages with the second portion 2016 at the second portion / upright fiber strut interface 2022. The plurality of interconnect fibers 2024 engage with the plurality of upright fiber struts 2018 at the upright fiber struts / interconnect fiber interface 2026.

The first portion 2012 and the second portion 2016 contain various biocompatible materials. The first and second portions 2012, 2016 may also be impregnated or coated with various agents such as hemostatic agents, antibacterial agents, or antimicrobial agents that may support the patient's recovery time. The first portion 2012 may have various thickness and material properties. In at least one embodiment, the first portion 2012 may have varying densities and elasticity to give the first portion 2012 the desired adaptive properties. Similarly, the second portion 2016 may have various thickness and material properties. In at least one embodiment, the second portion 2016 may have varying densities and elasticity to give the second portion 2016 the desired adaptive properties.

The upright fiber struts 2018 include one or more biocompatible materials. The upright fiber strut 2018 can be an elastic fiber having appropriate tensile strength and elasticity. The upright fiber struts 2018 may have uniform material properties and properties, or the material properties and properties may be varied to give the compressible auxiliary material 2100 the desired adaptive properties. In at least one embodiment, the upright fiber struts 2018 may be aligned in rows, and each row may have different material properties. When used with a surgical stapler, the upright fiber struts 2018 located closest to the knife slot of the surgical stapler or closest to the incision have a higher degree of elasticity and the upright fiber struts 2018 bend. Or it may require more force before it is buckled. This can result in an increase in pressure near the incision, which can be beneficial in the treatment of the patient. Alternatively, in certain cases, the upright fiber struts 2018 located closest to the knife slot of the surgical stapler or closest to the incision have higher elasticity and the upright fiber struts 2018 bend or It may require less force to be buckled.

In other embodiments, the material properties of the upright fiber struts 2018 can vary from proximal to distal to give the compressible auxiliary material 2000 the desired adaptive properties. Multiple upright fiber struts 2018 may include varying densities and cross-sectional areas or diameters. If the upright fiber struts 2018 contain a relatively denser or larger cross-sectional area or diameter, the force required to influence the desired flexure of the upright fiber struts 2018 may increase. Similarly, if the upright fiber struts 2018 contain a relatively lower density or smaller cross-sectional area or diameter, the force required to influence the desired flexure may be reduced. In addition, the density and cross-sectional area or diameter of the upright fiber struts 2018 is such that the upright fiber struts 2018 have various bending moments when the force is increased or the compressible aid 2000 associates with the thickness varying structure T. Can be varied to be able to have. In such one embodiment, the upright strut fibers 2018 may have a higher density in the portion closer to the second portion 2016 and a lower density in the portion closer to the first portion 2012. This may allow for increased elasticity of the compressible auxiliary material 2000 when additional compressive force is applied, and the force and compression profile will vary with respect to the displacement and compression of the compressible auxiliary material 2000.

The upright fiber strut 2018 engages with the first portion 2012 at the first portion / upright fiber strut interface 2020. The first portion / upright fiber strut interface 2020 may be one of the frictional or resistance relationships in which the upright fiber strut 2018 is not fixably attached to the first portion 2012. In another embodiment, the upright fiber strut 2018 may be fixedly or releasably attached to the first portion 2012 at the first portion / upright fiber strut interface 2020. In at least one embodiment, the upright fiber struts 2018 may be embedded in the first portion 2012. In an alternative embodiment, the upright fiber struts 2018 are attached to, bonded, welded, melted, hooked, woven, or woven to the first portion 2012. , Or can be fastened.

The upright fiber strut 2018 engages with the second portion 2016 at the second portion / upright fiber strut interface 2022. The second portion / upright fiber strut interface 2022 may be one of the frictional or resistance relationships in which the upright fiber strut 2018 is not fixably attached to the second portion 2016. In another embodiment, the upright fiber strut 2018 may be fixedly or releasably attached to the second portion 2016 at the second portion / upright fiber strut interface 2022. In at least one embodiment, the upright fiber struts 2018 may be embedded in the second portion 2016. In an alternative embodiment, the upright fiber struts 2018 are attached, glued, welded, melted, hooked, woven, or woven to the second portion 2016. , Or can be fastened.

The plurality of interconnect fibers 2024 include one or more biocompatible materials. The interconnect fiber 2024 can be an elastic fiber having appropriate tensile strength and elasticity. The interconnect fiber 2024 may have uniform material properties and properties, or the material properties and properties may be varied to give the compressible auxiliary material 2000 the desired adaptive properties.

In at least one embodiment, the interconnect fibers 2024 may be aligned in rows or columns to form a matrix, and each row and / or column may have different material properties. When used with a surgical stapler, the interconnect fibers 2024 placed closest to the knife slot or incision of the surgical stapler can be more elastic, while the interconnect fibers 2024 further away from the knife slot are more elastic. Can be a target. This can generate and increase pressure near the incision, which can be beneficial in the treatment of the patient. Alternatively, in certain cases, the interconnect fibers 2024 placed closest to the knife slot or incision of the surgical stapler can be more elastic, while the interconnect fibers 2024 further away from the knife slot are more. Can be elastic.

In other embodiments, the material properties of the interconnect fibers 2024 can vary from proximal to distal depending on the patient's needs. The interconnect fibers 2024 may include varying densities and cross-sectional areas or diameters. When interconnected fibers 2024 with a relatively denser or larger cross-sectional area or diameter are used, the tension required to influence the desired flexure of the interconnected fibers 2024 increases. Similarly, if the interconnect fibers 2024 have a lower density or a smaller cross-sectional area or diameter, the tension required to influence the desired flexure of the interconnect fibers 2024 is reduced. In addition, the density and cross-sectional area or diameter of the interconnect fiber 2024 indicates that the interconnect fiber 2024 has various physical properties and elasticity when the compressible aid 2000 associates with a structure T of varying thickness. As possible, it can vary between the proximal portion of the staple cartridge 12 and the distal portion of the staple cartridge 12.

The upright fiber struts 2018 and the interconnect fibers 2024 engage with each other at the upright fiber struts / interconnect fiber interface 2026. The upright fiber struts / interconnect fiber interface 2026 can be one of the frictional or resistance relationships in which the upright fiber struts 2018 are not fixably attached to the interconnect 2020. In another embodiment, the upright fiber struts 2018 may be fixedly, releasably, or slidably attached to the interconnect fibers 2024 at the upright fiber struts / interconnect fiber interface 2026. In at least one embodiment, the upright fiber struts 2018 may be embedded in interconnect fibers 2024. In an alternative embodiment, the upright fiber struts 2018 are attached to, bonded, welded, melted, hooked, woven, or rolled to interconnect fibers 2024. Or it can be fastened.

The interconnect fibers 2024 can also provide additional stability for each upright fiber strut 2018 and for the entire compressible auxiliary material 2000. Referring again to FIG. 40, the interconnect fibers 2024 are separated between the first portion 2012 and the second portion 2016. The three interconnect fibers 2020 are engaged with each upright fiber strut 2018 that is substantially equidistant from each other, although any suitable number of interconnect fibers 2020 may be used. In another embodiment, the number of interconnect fibers 2024 is to increase the stability of the upright fiber struts 2018 or to increase the elasticity and force required to compress the compressible aid 2000. Can be increased to. In another embodiment, the spacing and amount of interconnect fibers 2024 can be adjusted to give the compressible auxiliary material 2000 the desired adaptive properties. If the interconnect fibers 2024 are placed closer to the second portion 2016, the compressible auxiliary material 2000 will also have higher rigidity in the portion of the compressible auxiliary material 2000 closest to the second portion 2016. It has lower stiffness in the portion of the compressible auxiliary material 2000 closest to the first portion 2012.

Referring to FIG. 41, the compressible auxiliary material 2100 is shown, in at least one embodiment, partially compressed by the tissue T. The staples 2102 engage the compressible aid 2100 as the staples 2102 are fired and molded by the surgical stapler. The molded staple 2102 has a staple base 2104, a first staple leg 2106, and a second staple leg 2108. In this embodiment, the first staple leg 2106 engages the tissue T and the compressible aid 2100.

The compressible auxiliary material 2100 includes a first portion 2112 having a tissue contact interface 2110. When the compressible aid 2100 engages the tissue T, the tissue contact interface 2110 contacts and interacts with the tissue T. The compressible auxiliary material 2100 includes a second portion 2116 having a cartridge interface 2114. The cartridge interface 2114 may be releasably attached or placed on or adjacent to the staple cartridge deck 16.

The compressible auxiliary material 2100 includes a central portion disposed between the first portion 2112 and the second portion 2116. The central portion comprises a plurality of upright fiber struts 2118 and a plurality of interconnect fibers 2124, although any suitable number of interconnect fibers 2124 may be used. The upright fiber strut 2118 engages the first portion 2112 at the first portion / upright fiber strut interface 2120. The upright fiber strut 2118 engages the second portion 2116 at the second portion / upright fiber strut interface 2122. The interconnect fibers 2124 engage with a plurality of upright fiber struts 2118 at the upright fiber struts / interconnect fiber interface 2126.

The first portion 2112 and the second portion 2116 contain one or more biocompatible materials. The first and second portions 2112 and 2116 may also be impregnated or coated with various agents such as hemostatic agents, antibacterial agents, or antimicrobial agents that may assist the patient's recovery time. The first portion 2112 may have various thickness and material properties. In at least one embodiment, the first portion 2112 may have varying densities and elasticity to give the first portion 2112 the desired adaptive properties. Similarly, the second portion 2116 can have various thickness and material properties. In at least one embodiment, the second portion 2116 may have varying densities and elasticity to give the second portion 2116 the desired adaptive properties.

The upright fiber struts 2118 include one or more biocompatible materials. The upright fiber struts 2118 can be elastic fibers with appropriate tensile strength and elasticity. The upright fiber struts 2118 may have uniform material properties and properties, or the material properties and properties may vary to give the compressible auxiliary material 2100 the desired adaptive properties. In at least one embodiment, the upright fiber struts 2118 may be aligned in rows, and each row may have different material properties. When used with a surgical stapler, the upright fiber struts 2118 located closest to the knife slot of the surgical stapler or closest to the incision have a higher degree of elasticity and the upright fiber struts 2118 bend. Or it may require more force before it is buckled. This can result in an increase in pressure near the incision, which can be beneficial in the treatment of the patient. Alternatively, in certain cases, the upright fiber struts 2118 located closest to the knife slot of the surgical stapler or closest to the incision have higher elasticity and the upright fiber struts 2118 are bent or It may require less force to be buckled.

In other embodiments, the material properties of the upright fiber struts 2118 can vary from proximal to distal to give the compressible auxiliary material 2100 the desired adaptive properties. The plurality of upright fiber struts 2118 may include varying densities and cross-sectional areas or diameters. If the upright fiber struts 2118 contain a relatively denser or larger cross-sectional area or diameter, the force required to influence the desired flexure of the upright fiber struts 2118 may increase. Similarly, if the upright fiber struts 2118 have a relatively lower density or a smaller cross-sectional area or diameter, the force required to influence the desired flexure may be reduced. In addition, the density and cross-sectional area or diameter of the upright fiber struts 2118 is such that the upright fiber struts 2118 have various bending moments when the force increases or the compressible aid 2100 associates with a thickness-variable structure T. Can be varied to be able to have. In such one embodiment, the upright strut fibers 2118 may have a higher density in the portion closer to the second portion 2116 and a lower density in the portion closer to the first portion 2112. This may allow for increased elasticity of the compressible auxiliary material 2100 when additional compressive force is applied, and the force and compression profile will vary with respect to the displacement and compression of the compressible auxiliary material 2100.

The upright fiber strut 2118 engages the first portion 2112 at the first portion / upright fiber strut interface 2120. The first portion / upright fiber strut interface 2120 may be one of the frictional or resistance relationships in which the upright fiber strut 2118 is not fixably attached to the first portion 2112. In another embodiment, the upright fiber struts 2118 may be fixedly or releasably attached to the first portion 2112 at the first portion / upright fiber stanchion interface 2120. In at least one embodiment, the upright fiber struts 2118 may be embedded in the first portion 2112. In an alternative embodiment, the upright fiber struts 2118 are attached to, bonded, welded, melted, hooked, woven, or woven to the first portion 2112. , Or can be fastened.

The upright fiber strut 2118 engages the second portion 2116 at the second portion / upright fiber strut interface 2122. The second portion / upright fiber strut interface 2122 may be one of the frictional or resistance relationships in which the upright fiber strut 2118 is not fixably attached to the second portion 2116. In another embodiment, the upright fiber struts 2118 may be fixedly or releasably attached to the second portion 2116 at the second portion / upright fiber stanchion interface 2122. In at least one embodiment, the upright fiber struts 2118 may be embedded in the second portion 2116. In an alternative embodiment, the upright fiber struts 2118 are attached to, bonded, welded, melted, hooked, woven, or braided to the second portion 2116. , Or can be fastened.

Interconnected fibers 2124 include one or more biocompatible materials. The interconnect fiber 2124 can be an elastic fiber having appropriate tensile strength and elasticity. The interconnect fibers 2124 may have uniform material properties and properties, or the material properties and properties may be varied to give the compressible auxiliary material 2100 the desired adaptive properties.

In other embodiments, the material properties of the interconnect fibers 2124 can be varied proximally to give the desired adaptive properties. Interconnect fibers 2124 may include varying densities and cross-sectional areas.

When interconnected fibers 2124 containing relatively denser or larger cross-sectional areas or diameters are used, the tension required to influence the desired flexure of the interconnected fibers 2124 increases. Similarly, if the interconnect fibers 2124 have a lower density or a smaller cross-sectional area or diameter, the tension required to influence the desired flexure of the interconnect fibers 2024 is reduced. In addition, the density and cross-sectional area or diameter of the interconnect fibers 2124 indicates that the interconnect fibers 2124 have various physical properties and elasticity when the compressible aid 2100 associates with a thickness varying structure T. As possible, it can vary between the proximal portion of the staple cartridge 12 and the distal portion of the staple cartridge 12.

The upright fiber struts 2118 and interconnected fibers 2124 engage with each other at the upright fiber struts / interconnected fiber interface 2126. The upright fiber struts / interconnect fiber interface 2126 can be one of the frictional or resistance relationships in which the upright fiber struts 2118 are not fixably attached to the second portion 2124. In another embodiment, the upright fiber struts 2118 can be fixedly, releasably, or slidably attached to the interconnected fibers 2124 at the upright fiber struts / interconnected fiber interface 2126. In at least one embodiment, the upright fiber struts 2118 may be embedded in interconnect fibers 2124. In an alternative embodiment, the upright fiber struts 2118 are attached to, bonded, welded, melted, hooked, braided, or woven to interconnect fibers 2124. Can be rolled or fastened.

The interconnect fibers 2124 can also provide additional stability to the entire compressible auxiliary material 2100 and to each upright fiber strut 2118. Referring again to FIG. 41, a single interconnect fiber 2124 is spaced between the first portion 2112 and the second portion 2116. A single interconnect fiber 2124 engages with each upright fiber strut 2118 at a substantially midpoint of the upright fiber strut 2118. In other embodiments, the number of interconnected fibers 2124 increases the elasticity and force required to increase the stability of the upright fiber struts 2118 or to compress the compressible aid 2100. Can be increased to. In another embodiment, the spacing of the interconnect fibers 2124 can be adjusted to give the compressible aid 2100 the desired adaptive properties. When the interconnect fibers 2124 are placed closer to the second portion 2116, the compressible auxiliary material 2100 has higher rigidity in the portion of the compressible auxiliary material 2100 closest to the second portion 2116. It has lower stiffness in the portion of the compressible auxiliary material 2100 closest to the first portion 2112.

Referring to FIG. 41, the interface 2126 can be in the form of a slip joint that allows the interconnect fibers 2124 to slip, move, and / or shift between the upright fiber struts 2118. This feature allows the upright fiber struts 2118 to flex freely at various angles while maintaining a bond engagement with other upright fiber struts 2118 through the slip joint interface defined by the interconnect fibers 2124. It becomes possible.

With reference to FIG. 42, the compressible auxiliary material 2200 is shown. The compressible auxiliary material 2200 is engaged with a structure T having various structure thicknesses. The tissue T has a first tissue thickness T1 and a second tissue thickness T2. At least one staple 2202 engages the compressible aid 2200. The staple 2202 has a staple base 2204 and a first staple leg 2206 and a second staple leg 2208 extending from the staple base 2204. The staple 2202 is molded and a portion of the first staple leg 2206 and the second staple leg 2208 engages the tissue T and the compressible aid 2200.

The compressible auxiliary material 2200 includes a tissue contact interface 2210 configured to interact with the adjacent tissue T. The compressible aid 2200 can be used in a variety of surgical procedures and can be used in surgical staplers or staple cartridges. The compressible auxiliary material 2200 includes a cartridge interface 2214 that can be mounted on or fixedly attached to the deck 16 of the staple cartridge 12. The compressible auxiliary material 2200 may include a plurality of upright fiber support portions 2214 and a compressible auxiliary material base portion 2216. The plurality of upright fiber support portions 2214 may extend from the compressible auxiliary material base portion 2216.

The compressible auxiliary material 2200 is engaged with a structure T having various thicknesses T1 and T2. In response to the tissue thickness, the compressible auxiliary material 2200 is compressed to a first compression height H1 and a second compression height H2. In this embodiment, the compressible auxiliary material 2200 has responsiveness and compatibility with respect to the structure T having a variable thickness. The compressible auxiliary material 2200 contains one or more biocompatible materials.

The upright fiber support portion 2214 can be adapted and configured to have a variety of material properties. The upright fiber support portion 2214 can have various densities, cross-sectional areas and diameters, as well as perforations. The upright fiber support portion 2214 may include a plurality of woven or twisted fibers within each upright fiber support portion 2214. These individual fibers can have varying densities, cross-sectional areas and diameters, as well as perforations. Each upright fiber support portion 2214 contains at least two twisted fibers and is fixably attached to the compressible auxiliary material base portion 2214. Alternatively, the upright fiber support portion 2214 may be releasably or slidably attached to the compressible auxiliary base portion 2216. In at least one embodiment, the upright fiber support portion 2214 may be embedded in the compressible auxiliary material base portion 2216. In an alternative embodiment, the upright fiber support portion 2214 is attached to, bonded, welded, melted, hooked, or woven into the compressible auxiliary base portion 2216. It can be woven, wrapped, or fastened.

In at least one embodiment, each upright fiber support portion 2214 may include at least two fibers that are twisted or meshed with each other. The twisted fibers can be adjusted to affect the desired elasticity and compressibility of the compressible auxiliary material 2200. In at least one embodiment, the fibers of the upright fiber support portion 2214 may be twisted or wound more tightly in a portion of the upright fiber support portion 2214 near the compressible auxiliary base portion 2216. Similarly, the fibers of the upright fiber support portion 2214 may be twisted or wound more loosely in a portion of the upright fiber support portion 2214 near the tissue contact interface 2210. Due to the variable fiber stiffness of the upright fiber support portion 2214, the compressibility of the compressible auxiliary material 2200 can vary. In another embodiment, the fibers of the upright fiber support portion 2214 untwist when the compressible aid 2200 associates with a structure having a thicker thickness or when the upright fiber support portion 2214 receives higher resistance. Or it can be configured to unwind.

In another embodiment, the axial strength of the upright fiber support portion 2214 can be adjusted and adapted to give the compressible aid 2200 the desired adaptive properties. The upright fiber support portion 2214 can also unravel where the fibers of the upright fiber support portion 2214 are closer to the tissue contact interface 2210, creating a dynamic system that can be compressed near the compressible auxiliary base portion 2216. This dynamic system allows the compressible aid 2200 to interact dynamically with tissues of varying thickness. The upright fiber support portion 2214 can be adaptively adjusted to increase the compressibility of the compressible aid 2200 when engaged with a thicker portion of the structure. When the upright fiber support portion 2214 engages with a thinner portion of the structure, the compressible auxiliary material 2200 may still be more rigid to compensate for the fluctuating structure thickness. This dynamic ability, adjusted for structures with varying thicknesses, helps facilitate proper staple forming and compression to secure the engaged tissue T.

With reference to FIG. 43, fiber 2300 is shown. Fiber 2300 can have different materials and physical properties and can be made to have different shapes, dimensions and lengths. As shown in FIG. 43, the fiber 2300 has a circular or at least substantially circular shape. In other embodiments, the fiber 2300 may have a square, rectangular, oval, octagonal, or any other cross-sectional shape. Fiber 2300 can be soft and elastic and can be used in the production of the various compressible aids of the present disclosure. Fiber 2300 comprises one or more biocompatible materials.

The material composition, height, and / or cross-sectional area of the fiber 2300 affects its stiffness, that is, its ability to bend under compression. The stiffness of the fiber 2300 can be adjusted to adjust the compressibility of the compressible aid to one or more desired values.

With reference to FIG. 44, fiber 2400 is shown. The fiber 2400 has undergone a gas sorption process. The gas sorption process fills the fiber inner portion 2406 of the fiber 2400 with a plurality of fiber inner holes 2408. The outer fiber surface 2402 of the fiber 2400 can also be altered through a gas sorption process to include a plurality of outer fiber surface holes 2404.

Batch foaming by gas sorption process involves selecting the substrate or fiber 2400 to be used. The method further comprises pushing the gas into the fiber 2400 or substrate at high pressure. The pressure is then reduced and as a result the treated fiber 2400 or substrate can expand. The expanded fiber 2400 or substrate may have increased porosity, decreased density, and / or increased cross-sectional surface area and diameter. The gas sorption process can be advantageous over other conventional methods as it allows the material properties, such as the stiffness of the fiber 2400, to be adjusted and adjusted without the need for chemical solvents.

The gas sorption batch foaming process can be applied to a variety of substrates. In at least one embodiment, the method of gas sorption batch foaming can be applied to biocompatible polymer films that can be used as implantable devices or compressible aids. Gas at high pressure can be pushed into the polymer film. The polymer film can then be expanded into a closed cell structure by reducing the pressure. The polymer film can have a compressible closed cell structure without the need for chemical solvents.

Another desirable substrate for the gas sorption process includes meltblown non-woven structures. In various cases, the meltblown process extrudes the molten polymer through the orifice and blows the molten polymer from near the orifice onto the conveyor or take-up screen to form a fibrous non-woven structure. Includes thinning the extruded product into fibers.

Meltblown non-woven structures rapidly increase in stiffness as the thickness increases. In certain cases, a compressible aid with a thicker thickness is desired without increasing the stiffness associated with it. This presents the limits of the melt blown process. In certain cases, compressible auxiliaries with thicker thickness and appropriate stiffness can be obtained using chemical solvents.

Referring to FIG. 45, a compressible auxiliary material 2500 with a thicker thickness and appropriate rigidity is produced without resorting to chemical solvents. The compressible auxiliary material 2500 is made by a meltblown process to produce a meltblown non-woven intermediate substrate with a plurality of fibers 2501. The meltblown non-woven intermediate substrate is further processed by a gas sorption process to produce the appropriate stiffness. By further treating the meltblown non-woven intermediate substrate in a gas sorption process, the intermediate substrate can be expanded and the density, compressibility and / or porosity can be adjusted to the desired parameters.

Melt blown non-woven intermediate substrate is produced using the melt blown process. Other suitable techniques may also be used to produce suitable substrates for the gas sorption process. In at least one case, an electrospinning process can be used. In at least one case, it can be produced by knitting, weaving, or any other suitable process.

One or more of the compressible aids of the present disclosure may be modified by a gas sorption process to adjust the density, compressibility, and / or porosity to the desired parameters. The various struts, spacer fibers, erecting fibers, and / or loop members of the compressible aids of the present disclosure are gas sorption processes to adjust the density, compressibility, and / or porosity to the desired parameters. Can be improved by

Referring to FIG. 45, the outer fiber surface 2502 may form outer fiber surface holes 2504 by the gas sorption process. In addition, the gas sorption process may fill the fiber inner portion 2506 with a plurality of fiber inner holes 2508. Through the gas sorption process, the intermediate substrate can be expanded in volume while reducing the density and increasing the porosity of the substrate. Some potential advantages of the combination process are the increased perforation achieved by combining the melt blown process and the gas scavenging process, which enhances the internal growth of the tissue into the compressible aid 2500. Can be mentioned. As shown in FIG. 45, the compressible auxiliary material 2500 contains a plurality of holes 2510 created between the fibers 2501 in the melt blown process in addition to the holes created by the gas sorption process in the individual fibers 2501. ..

Once the compressible auxiliary material 2500 is formed to the desired properties, further treatment can be performed. In at least one embodiment, a plurality of compressible aids 2500 may be laminated to increase the thickness of the entire structure or to add different material properties. In at least one embodiment, a compressible auxiliary material 2500 made from different materials or made with different pores and densities may be used. In one example, the density and porosity closer to the tissue interface can be further enhanced to enhance the internal growth of the tissue. Multiple compressible aids can be adhered by melting, fastening, gluing, knitting, weaving, hooking, and other gluing techniques.

The compressible auxiliary material 2500 can be further improved by coating or embedding various substances in the compressible auxiliary material 2500. In at least one embodiment, it may be beneficial to coat or inject a hemostatic, antibacterial, or antibacterial agent into the compressible aid 2500.

Various embodiments are disclosed, including auxiliary materials attached to and / or auxiliary materials placed on the staple cartridge. It should be understood that such teachings are applicable to embodiments in which the auxiliary material is attached and / or placed on the anvil of the surgical instrument. In fact, embodiments are contemplated in which the first auxiliary material is attached and / or placed on the cartridge and the second auxiliary material is attached and / or placed on the anvil.

The compressible auxiliary material of the present disclosure may be arranged with respect to the cartridge deck of the staple cartridge, for example, the cartridge deck 16 of the staple cartridge 12. In at least one case, the compressible aid is applied to the cartridge deck of the staple cartridge prior to loading the staple cartridge onto a surgical instrument such as, for example, a surgical staple fastener and cutting instrument 8010 (FIG. 1). Can be placed. Alternatively, the compressible aid may be placed against the cartridge deck of the staple cartridge after the staple cartridge has been loaded into a surgical staple fastener and cutting instrument. A loading unit can be used to place the compressible aid on the cartridge deck of the staple cartridge. The loading unit may include various attachment and / or placement mechanisms for operating and placing the compressible aid with respect to the cartridge deck. When the compressible auxiliary material is correctly placed with respect to the cartridge deck, the loading unit may release the compressible auxiliary material.

In addition to the above, the compressible aid can be placed against the cartridge deck without sticking to the staple cartridge. Alternatively, the compressible aid may be attached to the staple cartridge before or after the staple cartridge has been loaded into the surgical stapler and cutting instrument. For example, the compressible auxiliary material may be partially melted onto the cartridge deck and then resolidified by cooling, which will bond the compressible auxiliary material to the cartridge deck. Also, various attachment mechanisms, such as sutures, straps, spines, and / or other mechanical attachment mechanisms, can be used to attach the compressible aid to the staple cartridge.

Example 1-Compressible aid for use with surgical instruments including staple cartridges, a first biocompatibility layer and a second biocompatibility separated from the first biocompatibility layer. A compressible auxiliary material comprising a layer and a plurality of support stanchions extending between the first biocompatible layer and the second biocompatible layer.

Example 2-Each of the support struts comprises a first termination portion attached to a first biocompatibility layer and a second termination portion attached to a second biocompatibility layer. The compressible auxiliary material of Example 1.

Example 3-The compressible auxiliary material of Example 2 in which the first termination portion and the second termination portion define a horizontal axis that intersects the first biocompatibility layer and the second biocompatibility layer.

Example 4-The horizontal axis defines a first angle with respect to the first biocompatible layer, the horizontal axis defines a second angle with respect to the second biocompatible layer, and the first The compressible auxiliary material of Example 3, wherein the angle and the second angle are selected from the range of about 80 ° to about 100 °.

Example 5-The first termination portion is the compressible auxiliary material of Examples 2, 3 or 4 woven into the first biocompatibility layer.

Example 6-The compressible auxiliary material of Example 2, 3, 4, or 5 in which the first termination portion is welded to the first biocompatible layer.

Example 7-The plurality of support struts of Example 1, 2, 3, 4, 5, or 6 comprising a first support stanchion and a second support stanchion that intersects the first support stanchion. Compressible auxiliary material.

Example 8-A compressible aid of Example 1, 2, 3, 4, 5, 6, or 7, wherein at least one of the first biocompatible layer and the second biocompatible layer comprises a matrix of woven fabrics. Material.

Example 9-The compressibility of Example 1, 2, 3, 4, 5, 6, 7 or 8, wherein at least one of the first biocompatible layer and the second biocompatible layer comprises a knitted matrix. Auxiliary material.

Example 10-The compressible auxiliary material of Example 1, 2, 3, 4, 5, 6, 8 or 9, wherein at least one of the first biocompatible layer and the second biocompatible layer contains a film. ..

Example 11-The second biocompatible layer comprises an outer surface configured to grip the tissue, the compressibility of Examples 1, 2, 3, 4, 5, 6, 8, 9, or 10. Auxiliary material.

Example 12-The compressible aid of Example 11 wherein the outer surface comprises a plurality of gripping mechanisms, each of which defines an acute angle with respect to the outer surface.

Examples 13-The first biocompatible layer has a higher density than the second biocompatible layer, Examples 1, 2, 3, 4, 5, 6, 8, 9, 10, 11 or. 12 compressible aids.

Example 14-The main body portion and an outer edge portion that at least partially surrounds the main body portion, wherein the main body portion further includes an outer edge portion having a thickness thicker than that of the outer edge portion. 2, 3, 4, 5, 6, 8, 9, 10, 11, 12, or 13 compressible aids.

Example 15-Compressible auxiliary material of Example 14, the outer edge is tapered.

Example 16-The outer edge is a first outer edge extending from the first biocompatibility layer and a second outer edge extending from the second biocompatibility layer, the first outer edge. The portion and the second outer edge portion are integrated into a continuous lateral portion configured to join the first biocompatible layer and the second biocompatible layer. The compressible aid of Example 14 or 15, comprising a second outer edge.

Example 17-Additional knife slots configured to receive knives for cutting tissue captured by surgical instruments, knife slots defining two sides, knives on two sides. The compressible auxiliary material of Example 1, 2, 3, 4, 5, 6, 8, 9, 10, 11, 12, 13, 14, 15, or 16 passing between.

Example 18-The compressible aid of Example 17, further comprising a tether extending between the two sides, the knife being configured to cut the tether to separate the two sides.

Example 19-A staple cartridge assembly for use with a surgical staple fastener, comprising a staple cartridge comprising a plurality of staples and a cartridge deck with an outer surface. The staple cartridge assembly further comprises a compressible aid that can be placed with respect to the outer surface, which is a biocompatible layer facing the tissue and a biocompatibility facing the deck that can be placed with respect to the outer surface. The biocompatibility layer facing the tissue and the biocompatibility layer facing the deck is separated from the biocompatibility layer facing the deck, and the spacer fibers are the biocompatibility layer facing the tissue and the biocompatibility facing the deck. Intersecting the layers, the spacer fibers are configured to lift the tissue-facing biocompatible layer onto the deck-facing biocompatible layer.

Example 20-A compressible aid for use with surgical instruments including staple cartridges, a first biocompatibility layer and a second biocompatibility separated from the first biocompatibility layer. A layer is provided with an elongated soft member that interconnects a first biocompatible layer and a second biocompatible layer, and the elongated soft member comprises a first biocompatible layer and a second biocompatibility. Compressible aids configured to form multiple upright support structures with layers.

Example 21-A staple cartridge assembly for use with a surgical staple fastener, comprising a plurality of staples, a cartridge deck, and a staple cartridge. The staple cartridge assembly further comprises a compressible auxiliary material that can be placed against the cartridge deck, the staples can be deployed in the tissue captured against the compressible auxiliary material, and the compressible auxiliary material is the first. A first biocompatible layer comprising a portion 1, a second biocompatible layer comprising a second portion, and crossed spacer fibers extending between the first portion and the second portion. Be prepared.

Example 22-A staple cartridge assembly for use with a surgical staple fastener, comprising a plurality of staples, a cartridge deck, and a staple cartridge. The staple cartridge assembly further comprises a compressible auxiliary material that can be placed against the cartridge deck, the staples can be deployed in the tissue captured against the compressible auxiliary material, and the compressible auxiliary material is the first. A staple cartridge assembly comprising a tissue-facing layer comprising one connecting node and a second connecting node arranged in a first row with the first connecting node. The compressible auxiliary material further comprises a layer facing the deck, the layer facing the tissue is separated from the layer facing the deck, and the layer facing the deck is a third aligned perpendicular to the first connecting node. And a fourth joint that is vertically aligned with the second joint, the fourth joint is vertically aligned with the second joint and the fourth joint. The nodes are arranged in a second column with a third connecting node. The compressible auxiliary material is a first spacer fiber extending between the first and fourth joint nodes and a second spacer fiber extending between the second and third joint nodes. The first spacer fiber intersects the second spacer fiber.

23-The staple cartridge assembly of Example 22, where the first row is parallel to the second row.

Example 24-The staple cartridge assembly of Example 22 or 23, wherein the first row further comprises a fifth coupling node between the first coupling node and the second coupling node.

Example 25-A staple cartridge assembly of Example 24 further comprising a first fibrous portion that interconnects a first and fifth coupling node.

Example 26-The staple cartridge assembly of Example 24 or 25 further comprising a second fibrous portion that interconnects the second and fifth coupling nodes.

Example 27-The staple cartridge assembly of Example 22, 23, 24, 25, or 26, wherein the second column further comprises a sixth coupling node between the third coupling node and the fourth coupling node. ..

Example 28-A staple cartridge assembly of Example 27 further comprising a third fibrous portion that interconnects a third and sixth coupling node.

Example 29-A staple cartridge assembly of Example 27 or 28 further comprising a fourth fiber portion that interconnects a fourth and sixth coupling node.

The staple cartridge assembly of Example 27, 28, or 29, wherein the fifth joint node is aligned perpendicular to the sixth joint node.

Example 31-A staple cartridge assembly for use with a surgical staple fastener, comprising a staple cartridge comprising a plurality of staples and a cartridge deck defining a proximal end and a distal end. , Staple cartridge assembly. The staple cartridge assembly further comprises a compressible auxiliary material that can be placed against the cartridge deck, the staples can be deployed in the tissue captured against the compressible auxiliary material, and the compressible auxiliary material is the first. A staple cartridge assembly comprising a tissue-facing layer comprising one connecting node and a second connecting node arranged in a first row with the first connecting node. The compressible auxiliary material further comprises a deck-facing layer, the tissue-facing layer is separated from the deck-facing layer, and the deck-facing layer comprises a third and fourth coupling node. , The fourth connecting node is arranged in a second column together with the third connecting node. The compressible auxiliary material includes a first spacer fiber extending from the first joint node to the third joint node and a second spacer extending proximally from the first joint node toward the surface facing the deck. Further comprises a fiber and a third spacer fiber extending distally from the first connecting node towards the surface facing the deck. The compressible auxiliary material further comprises a fourth spacer fiber extending from the second bond node to the fourth bond node.

Example 31-The staple cartridge assembly of Example 31 further comprising a fifth spacer fiber extending proximally from the second connecting node towards the surface facing the deck.

Example 33-The staple cartridge assembly of Example 31 or 32 further comprising a sixth spacer fiber extending distally from the second connecting node towards the surface facing the deck.

Example 34-6 Staple cartridge assembly of Example 33, wherein the sixth spacer fiber intersects the second spacer fiber.

Example 35-A staple cartridge assembly of Example 31, 32, 33, or 34 further comprising a seventh spacer fiber extending from a first bond node to a third bond node.

Example 36-A staple cartridge assembly of Example 31, 32, 33, 34, or 35 further comprising an eighth spacer fiber extending from a second binding node to a fourth binding node.

Example 37-The staple cartridge assembly of Example 31, 32, 33, 34, 35, or 36, wherein the first coupling node is vertically aligned with the third coupling node.

Example 38-The staple cartridge assembly of Example 31, 32, 33, 34, 35, 36, or 37, wherein the second coupling node is vertically aligned with the fourth coupling node.

Example 39-A staple cartridge assembly for use with a surgical staple fastener, comprising a staple cartridge comprising a plurality of staples and a cartridge deck defining a proximal end and a distal end. , Staple cartridge assembly. The staple cartridge assembly further includes compressible aids that can be placed against the cartridge deck, staples can be deployed within the tissue captured against the compressible aids, and compressible aids can be placed in the tissue. The layer facing the deck and the layer facing the deck are provided, the layer facing the tissue is separated from the layer facing the deck, and the layer facing the deck is provided with an outer surface and an inner surface. The compressible auxiliary material further comprises a first spacer fiber extending from the tissue facing layer toward the inner surface and a second spacer fiber extending from the tissue facing layer toward the inner surface. The spacer fibers and the second spacer fibers extend through a layer facing the deck and a loop defined by the first spacer fibers and the second spacer fibers on the outer surface.

Example 40-The staple cartridge assembly of Example 39, where the first spacer fibers and the second spacer fibers intersect in a layer facing the deck.

Example 41-A third spacer fiber further comprising a third spacer fiber extending from a layer facing the tissue, the third spacer fiber intersecting the first spacer fiber and the second spacer fiber in the layer facing the deck, Example. 39 or 40 staple cartridge assembly.

Example 42-A compressible aid for use with surgical instruments, including staple cartridges, comprising a biocompatible layer and a plurality of biocompatible loop members protruding from the biocompatible layer. Compressible auxiliary material. Each of the biocompatible loop members has a first termination portion attached to the biocompatibility layer, a second termination portion attached to the biocompatibility layer, a first termination portion and a second termination portion. With an intermediate curved portion extending between and, the intermediate curved portion is further separated from the biocompatibility layer as compared to the first and second termination portions.

Example 43-The compressible aid of Example 42 further comprising another biocompatible layer separated from the biocompatible layer.

Example 44-The compressible aid of Example 43, wherein the plurality of biocompatible loop members are disposed between a biocompatible layer and another biocompatible layer.

Example 45-The compressible auxiliary material of Example 43 or 44, wherein the intermediate curved portion is attached to another biocompatible layer.

Example 46-The compressible aid of Example 43, 44, or 45, wherein another biocompatible layer comprises a layer of woven fabric.

Example 47-The biocompatibility layer comprises a plurality of mooring islands separated from each other, each of which is a first and second termination portion of at least one of the biocompatibility loop members. The compressible aid of Example 42, 43, 44, 45, or 46, defined by the moiety.

Example 48-The mooring islands are the compressible aids of Example 47, arranged in parallel rows.

Example 49-Each of the biocompatible loop members comprises a wide head portion and a narrow neck portion extending between the wide head portion and the biocompatible layer, Examples 42, 43, 44, 45. 46, or 47 compressible aids.

Example 50-The compressible aid of Example 42, 43, 44, 45, 46, 47, or 48, each of which is composed of fibers.

Example 51-The compressible auxiliary material of Example 50, wherein the fibers are multifilament fibers.

Example 52-The biocompatible loop member is configured to bend in a disjointed manner in response to compressive forces, Examples 42, 43, 44, 45, 46, 47, 48, 49, 50. , Or 51 compressible aids.

Example 53-The biocompatible loop member is configured to bend in a cohesive manner in response to compressive forces, Examples 42, 43, 44, 45, 46, 47, 48, 49, 50, Or 51 compressible aids.

Example 54-A first biocompatible layer comprising a compressible aid for use with a surgical instrument including a staple cartridge, comprising a first fiber loop arranged in a plurality of first rows. And a second biocompatible layer that is separated from the first biocompatible layer and is arranged in a plurality of second rows separated from the plurality of first rows. A compressible auxiliary material comprising a second biocompatible layer comprising loops and a pair of first fiber moieties extending from each of the first fiber loops towards the second biocompatible layer. The compressible auxiliary material further comprises a pair of second fiber moieties extending from each of the second fiber loops towards the first biocompatible layer.

Example 55-The compressible aid of Example 54, wherein the first fiber portion is skewed to select bending in the first direction in response to compressive forces.

Example 56-The compressible aid of Example 55, wherein the second fiber portion is skewed to select bending in the first direction in response to compressive forces.

Example 57-The compressible aid of Example 54, 55, or 56, wherein the first and second fiber moieties are configured to bend in a disjointed manner in response to compressive forces. ..

Example 58-The compressible aid of Example 54, 55, or 56, wherein the first and second fiber moieties are configured to bend in a cohesive manner in response to compressive forces.

Example 59-A staple cartridge assembly for use with a surgical staple fastener, comprising a staple cartridge comprising a plurality of staples and a cartridge deck defining proximal and distal ends. , Staple cartridge assembly. The staple cartridge assembly further comprises a compressible auxiliary material that can be placed with respect to the cartridge deck, the compressible auxiliary material being separated from the first biocompatibility layer and the first biocompatibility layer. It comprises a biocompatible layer. The second biocompatible layer consists of a first fiber loop, a pair of first fiber moieties extending from the first fiber loop toward the first biocompatible layer, and proximal to the first fiber loop. A second fiber loop on the side, the pair of first fiber portions passing through the second fiber loop, from the second fiber loop to the first biocompatible layer. It comprises a pair of second fiber portions extending towards it.

Example 60-The second biocompatible layer is a third fiber loop located proximal to the second fiber loop, with a pair of second fiber portions passing through the third fiber loop. The staple cartridge assembly of Example 59 comprising a third fiber loop and a pair of third fiber moieties extending from the third fiber loop towards the first biocompatible layer.

Example 61-The staple cartridge assembly of Example 59 or 60, wherein the second layer is a layer of knitted fabric.

Example 62-A cartridge body comprising a deck and a plurality of staple cavities defined in the deck, and a plurality of staples removably stored in the staple cavity, and a staple cavity on top of the staple cartridge assembly. The implantable layer comprises an implantable layer, the top surface, the bottom surface, and the structural fibers woven into the strut wall extending between the top surface and the bottom surface, and within the strut wall. Staple cartridge assembly with woven reinforced fibers.

Example 63-The staple cartridge assembly of Example 62, in which the reinforcing fibers are woven within the top and bottom surfaces.

Example 64-The staple cartridge assembly of Example 62 or 63, wherein the reinforcing fibers are wrapped around structural fibers.

Example 65-The implantable layer has a first compression zone with a first density loop between the reinforcing and structural fibers and a second density loop between the reinforcing and structural fibers. The staple cartridge assembly of Example 62, 63, or 64, comprising a second compression zone, wherein the second density is higher than the first density.

Example 66-The cartridge body further comprises a longitudinal slot configured to receive the cutting member, the first compression zone is aligned with the longitudinal slot and the second compression zone is aligned with the staple cavity. The staple cartridge assembly of Example 65.

Example 67-The cartridge body comprises a proximal end and a distal end, the first compression zone is aligned with the proximal end, and the second compression zone is far from the first compression zone. The staple cartridge assembly of Example 62, 63, 64, 65, or 66 located on the position side.

Example 68-The cartridge body further comprises a longitudinal slot configured to receive the cutting member, the strut wall extending across the longitudinal slot, Example 62, 63, 64, 65, 66, or 67. Staple cartridge assembly.

Example 69-Staples of Example 62, 63, 64, 65, 66, 67, or 68, each structural fiber comprising a longitudinal seam extending between the proximal and distal ends of the cartridge body. Cartridge assembly.

Example 70-A staple cartridge assembly of Example 62, 63, 64, 65, 66, 67, 68, or 69, wherein each reinforcing fiber comprises a lateral seam extending through a strut wall.

Example 71-Structural fibers are composed of a first material and reinforcing fibers are composed of a second material different from the first material, Examples 62, 63, 64, 65, 66, 67, 68, 69, or 70 staple cartridge assembly.

Example 72-The staple cartridge assembly of Example 62, 63, 64, 65, 66, 67, 68, 69, 70, or 71, wherein the reinforcing fibers are associated with structural fibers.

Example 73-The implantable layer has a first compression zone with a first density nodule between the reinforcing and structural fibers and a second density nodule between the reinforcing and structural fibers. A second compression zone comprising, and a second density higher than the first density, staples of Examples 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, or 72. Cartridge assembly.

Example 74-A staple cartridge assembly that is placed on a deck and a cartridge body that includes a plurality of staple cavities defined within the deck, a plurality of staples housed within the staple cavities, and a staple cavity. A staple cartridge assembly comprising an implantable layer, the implantable layer comprising an interconnected structural wall composed of woven fibers and a pocket defined between the structural walls.

Example 75-The structural wall is composed of structural fibers woven into a top surface, a bottom surface, and a stanchion wall extending between the top surface and the bottom surface, and reinforced fibers woven within the stanchion wall. The staple cartridge assembly of Example 74.

Example 76-The staple cartridge assembly of Example 75, in which the reinforcing fibers are wrapped around structural fibers.

Example 77-The implantable layer has a first compression zone with a first density loop between the reinforcing and structural fibers and a second density loop between the reinforcing and structural fibers. The staple cartridge assembly of Example 75 or 76, comprising: a second compression zone, the second density of which is higher than the first density.

Example 78-The cartridge body further comprises a longitudinal slot configured to receive the cutting member, the first compression zone is aligned with the longitudinal slot and the second compression zone is aligned with the staple cavity. The staple cartridge assembly of Example 77.

Example 79-The cartridge body comprises a proximal end and a distal end, the first compression zone is aligned with the proximal end, and the second compression zone is far from the first compression zone. The staple cartridge assembly of Example 77 or 78, located on the side of the position.

Example 80-Staples of Example 75, 76, 77, 78, or 79, wherein the structural fibers are composed of a first material and the reinforcing fibers are composed of a second material different from the first material. Cartridge assembly.

Example 81-The cartridge body further comprises a longitudinal slot configured to receive the cutting member, the structural wall extending across the longitudinal slot, Example 75, 76, 77, 78, 79, or 80. Staple cartridge assembly.

Example 82-The staple cartridge of Example 75, 76, 77, 78, 79, 80, or 81, wherein the structural wall comprises a longitudinal seam extending between the proximal and distal ends of the cartridge body. assembly.

Example 83-The staple cartridge assembly of Example 82, wherein the structural wall further comprises a lateral seam that extends laterally with respect to the longitudinal seam.

Example 84-A staple cartridge assembly that is placed on a deck and a cartridge body that includes a plurality of staple cavities defined within the deck, a plurality of staples housed within the staple cavities, and a staple cavity. A staple cartridge assembly comprising an implantable layer, the implantable layer comprising a top portion, a bottom portion, and a wall woven between the top and bottom portions.

Example 85-A compressible aid comprising a first portion, a second portion, and a central portion, wherein the central portion is disposed between the first portion and the second portion. Mutually configured to engage a first strut, a second strut, and at least a first strut and a second strut that substantially extend between the first and second portions. The first strut is configured to flex only the first flexure and the second strut only the second flexure when compressed by a force with a connecting member and a compressible aid. A compressible aid that is configured to flex and the first flexure is different from the second flexure.

Example 86-The compressible auxiliary material of Example 85, wherein the interconnect member is fixedly engaged with a first strut and a second strut.

Example 87-The compressible auxiliary material of Example 85 or 86, wherein the interconnect member slides into a first strut and a second strut.

Example 88-The first strut comprises a first cross-sectional diameter, the second strut comprises a second cross-sectional diameter, and the first diameter is different from the second diameter, Examples 85, 86, or. 87 compressible aids.

Example 89-The compressible auxiliary material of Example 88, wherein the first cross-sectional diameter is larger than the second cross-sectional diameter and the second flexure is larger than the first flexure.

Example 90-The first strut comprises the first density, the second strut comprises the second density, the first density is different from the second density, Examples 85, 86, 87, 88. Or 89 compressible aids.

Example 91-The compressible auxiliary material of Example 90, wherein the first density is higher than the second density and the second flexure is greater than the first flexure.

Example 92-The first strut has a first cross-sectional diameter, the second strut has a second cross-sectional diameter, the interconnect member has a third cross-sectional diameter, the first cross-sectional diameter and the second. The compressible auxiliary material of Example 85, 86, 87, 88, 89, 90, or 91, wherein the cross-sectional diameter of the third is different from the third cross-sectional diameter.

Example 93-The first strut has a first density, the second strut has a second density, the interconnect members have a third density, and the first density and the second density have a second density. The compressible auxiliary material of Example 85, 86, 87, 88, 89, 90, 91, or 92, which is different from the density of 3.

Example 94-The first strut comprises a first end, a second end, and a central section, the first end engaging the first portion and the second end. The compressible auxiliary material of Example 85, 86, 87, 88, 89, 90, 91, 92, or 93, wherein the portion engages the second portion and the interconnect member engages the central section.

Example 95-Compressible aid, comprising a base portion, a plurality of struts, the plurality of struts comprising a first support with a first stanchion and a second stanchion, first. The strut and the second strut are engaged with the base portion, and the first strut and the second strut are interconnected, a compressible auxiliary material. The plurality of stanchions further comprises a second support with a third stanchion and a fourth stanchion, the third stanchion and the fourth stanchion engaging the base portion, the third stanchion and the fourth stanchion. The struts are interconnected and the first support is configured to flex only the first flexure and the second support is the second flexure when the compressible aid is compressed by some force. Only the flexures are configured to bend, the first flexure is different from the second flexure.

Example 96-The first support comprises a first material, the second support comprises a second material, the first material is different from the second material, the compressible aid of Example 95. Material.

Example 97-The first support has a first average density, the second support has a second average density, and the first average density is different from the second average density. The compressible auxiliary material of Example 95 or 96.

Example 98-The compressible auxiliary material of Example 97, wherein the first average density is higher than the second average density and the second flexure is greater than the first flexure.

Example 99-The first strut has a first cross-sectional diameter, the second strut has a second cross-sectional diameter, and the first diameter is different from the second diameter, Examples 95, 96, 97. , Or 98 compressible aids.

Example 100-The first strut has a first cross-sectional diameter, the second strut has a second cross-sectional diameter, the third strut has a third cross-sectional diameter, and the fourth strut has a fourth. The compressible auxiliary material of Example 95, 96, 97, 98, or 99 having a cross-sectional diameter of.

Example 101-The compressible auxiliary material of Example 100, wherein the first diameter is different from the third diameter and the second diameter is different from the fourth diameter.

Example 102-The first support has a first average height, the second support has a second average height, and the first height is different from the second height, Examples. 95, 96, 97, 98, 99, 100 or 101 compressible aids.

Example 103-The compressible aid of Example 102, wherein the first average height is higher than the second average height and the first flexure is greater than the second flexure.

Example 104-The first strut and the second strut are woven together so that the first strut and the second strut are partially unwound when the compressible aid is compressed. The compressible auxiliary material of Examples 95, 96, 97, 98, 99, 100, 101, 102, or 103.

Example 105-a method for producing a fibrous compressible structure having a desired thickness, 1. 2. A step of producing a biocompatible meltblown non-woven substrate having a thickness thinner than a desired thickness, wherein the biocompatible meltblown non-woven substrate comprises a plurality of fibers. A method comprising applying a gas sorption process to a biocompatible meltblown non-woven substrate to improve its thickness to a desired thickness.

Example 106-The method of Example 105, wherein the step of applying the gas sorption process comprises adding high pressure gas to a biocompatible meltblown non-woven substrate.

Example 107-The step of producing a biocompatible meltblown non-woven substrate is to extrude a polymer, to thin the extrude into fibers by the action of high temperature and high speed gas, and to form a fibrous non-woven fabric. The method of Example 105 or 106, comprising collecting fibers for.

Example 108-The step of applying the gas sorption process is as follows: 2. Adding high-pressure gas to the biocompatible meltblown non-woven substrate and 2. The method of Example 105, 106, or 107, comprising reducing the pressure of the gas.

Under various circumstances, one or more of the compressible aids of the present disclosure will be composed of one or more biocompatible materials. The compressible auxiliary material may include a polymeric composition. The polymer composition may comprise one or more synthetic polymers and / or one or more young non-synthetic polymers. The synthetic polymer may include a synthetic absorbent polymer and / or a synthetic non-absorbable polymer. In various situations, the polymer composition has a uniform pore morphology or a gradual pore morphology (ie, gradually increases in size to large pores throughout the thickness of the foam in the direction of the small pores). It may have a hole structure to have.

In various situations, the compressible auxiliary material has a hole morphology that exhibits a gradient structure, for example, small holes on one surface and larger holes on another surface. Such morphology may be more optimal for tissue inward growth or hemostatic activity. In addition, this gradient can be configured with various bioabsorption profiles. A short-term absorption profile is preferred to address hemostasis, while a long-term absorption profile may address better tissue healing without leakage.

In various situations, the polymeric composition may comprise a pharmaceutically active agent. The polymeric composition can release a therapeutically effective amount of the pharmaceutically active agent. In various situations, the pharmaceutically active agent can be released when the polymeric composition is desorbed / adsorbed. In various situations, the pharmaceutically active agent can be released onto or through the polymeric composition, eg, into a fluid such as blood.

The entire contents of the following disclosure are incorporated herein by reference. That is,
US Pat. No. 5,403,312, issued April 4, 1995, title of invention "ELECTROSURGICAL HEMOSTATTIC DEVICE";
U.S. Pat. No. 7,000,818 issued on February 21, 2006, title of invention "SURGICAL STAPLING INSTRUMENT HAVING SPECALTE DISTINCT CLOSEING AND FIRING SYSTEMS";
U.S. Pat. No. 7,422,139 issued September 9, 2008, title of invention "MOTOR-DRIVEN SURGICAL CUTTING AND FASTENING INSTRUMENT WITH TACTILE POSITION FEEDBACK";
US Pat. No. 7,464,849 issued on December 16, 2008, title of invention "ELECTRO-MEMHANICAL SURGICAL INSTRUMENT WITH CLOSE SYSTEM AND ANVIL ALIGNMENT COMPONENTS";
US Pat. No. 7,670,334 issued on March 2, 2010, title of invention "SURGICAL INSTRUMENT HAVING AN ARTICULATING END EFFECTOR";
U.S. Pat. No. 7,753,245 issued on July 13, 2010, title of invention "SURGICAL STAPLING INSTRUMENTS";
U.S. Pat. No. 8,393,514 issued on March 12, 2013, title of invention "SELECTIVELY ORIENTABLE IMPLANTABLE FASTENEER CARTRIDGE";
U.S. Patent Application No. 11 / 343,803, Invention Title "SURGICAL INSTRUMENT HAVING RECORDING CAPABILITIES", now U.S. Pat. No. 7,845,537;
U.S. Patent Application No. 12 / 031,573, filed February 14, 2008, title of invention "SURGICAL CUTTING AND FASTENING INSTRUMENT HAVING RF ELECTRODES";
U.S. Patent Application No. 12 / 031,873 filed February 15, 2008, title of invention "END EFFECTORS FOR A SURGICAL CUTTING AND STAPLING INSTRUMENT", now U.S. Pat. No. 7,980,443;
U.S. Patent Application No. 12 / 235,782, invention title "MOTOR-DRIVEN SURGICAL CUTTING INSTRUMENT", now U.S. Pat. No. 8,210,411;
U.S. Patent Application No. 12 / 249,117, Invention Title "POWERED SURGICAL CUTTING AND STAPLING APPARATUS WITH MANUALLY RETRACTABLE FIRING SYSTEM", now U.S. Patent No. 8,608,045;
US Pat. issue;
U.S. Patent Application No. 12 / 893,461 filed September 29, 2012, title of invention "STAPLE CARTRIDGE", now U.S. Pat. No. 8,733,613;
U.S. Patent Application No. 13 / 036,647 filed on February 28, 2011, title of invention "SURGICAL STAPLING INSTRUMENT", now U.S. Pat. No. 8,561,870;
U.S. Patent Application No. 13 / 118,241, title of invention "SURGICAL STAPLING INSTRUMENTS WITH ROTATABLE STAPLE DEPLOYMENT ARRANGEMENTS", now U.S. Pat. No. 9,072,535;
US Patent Application No. 13 / 524,049 filed June 15, 2012, title of invention "ARTICULATABLE SURGICAL INSTRUMENT COMPRISING A FIRING DRIVE", currently US Patent No. 9,101,358;
U.S. Patent Application No. 13 / 800,025 filed on March 13, 2013, title of invention "STAPLE CARTRIDGE TISSUE THICKNESS SENSOR SYSTEM", now U.S. Patent Application Publication No. 2014/0263551;
U.S. Patent Application No. 13 / 800,067 filed on March 13, 2013, title of invention "STAPLE CARTRIDGE TISSUE THICKNESS SENSOR SYSTEM", currently U.S. Patent Application Publication No. 2014/0263552;
US Patent Application Publication No. 2007/0175955 filed on January 31, 2006, the title of the invention "SURGICAL CUTTING AND FASTENING INSTRUMENT WITH CLOSE TRIGGER LOCKING MEMHANISM", and
US Patent Application Publication No. 2010/0264194 filed on April 22, 2010, title of invention "SURGICAL STAPLING INSTRUMENT WITH AN ARTICULATABLE END EFFECTOR", currently US Patent No. 8,308,040.

Although various embodiments of the device have been described herein in connection with the particular disclosed embodiments, many modifications and modifications can be made to those embodiments. Also, although the material is disclosed for a particular component, other materials may be used. Further, according to various embodiments, a single component may be replaced with a plurality of components, or a plurality of components may be replaced with a single component in order to perform a given function. .. The above description and the following claims are intended to include all such amendments and changes.

The devices disclosed herein can be designed to be discarded after a single use, or can be designed to be used multiple times. However, in either case, the device can be readjusted for reuse after at least one use. The readjustment can include any combination of a device disassembly step, a subsequent cleaning or replacement step of a particular part, and a subsequent reassembly step. In particular, the device is disassembled and any number of specific parts or parts of the device can be selectively replaced or removed in any combination. After cleaning and / or replacing certain parts, the device can be reassembled for later use by the surgical team at a readjustment facility or shortly before a surgical procedure. Those skilled in the art will appreciate that readjustment of the device can utilize a variety of techniques for disassembly, cleaning / replacement, and reassembly. The use of such techniques and the resulting readjusted devices are all within the scope of this application.

As a mere example, the embodiments described herein may be processed prior to surgery. First, new or used utensils may be obtained and cleaned as needed. The instrument can then be sterilized. In one sterilization technique, the instrument is placed in a closed and sealed container, such as a plastic bag or TYVEK bag. The vessel and instrument can then be placed in a radiation field that can penetrate the vessel, such as gamma rays, X-rays, or high energy electrons. Radiation can kill bacteria on instruments and in containers. After this, the sterilized instrument can be stored in a sterilized container. The sealed container can keep the instrument sterile until it is opened in a medical facility. The device can also be sterilized using any other technique known in the art, including but not limited to beta or gamma rays, ethylene oxide, hydrogen peroxide plasma, or water vapor.

Although the present invention has been described as having a representative design, the present invention may be further modified within the spirit and scope of the present disclosure. Accordingly, this application shall include any modification, use, or adaptation of the invention that uses its general principles.

Any patents, publications or other disclosures referred to herein in whole or in part by reference shall have incorporated content as described in the existing definition, description or disclosure. Incorporated herein only to the extent consistent with any other disclosure. As such, and to the extent necessary, the disclosures expressly set forth herein shall supersede any contradictory statements incorporated herein by reference. Any document, or any portion thereof, that is incorporated herein by reference but is inconsistent with the current definition, description, or other disclosure content described in this disclosure, is the reference document and the existing. It shall be used only to the extent that there is no contradiction with the disclosure content of.

[Implementation mode]
(1) Staple cartridge assembly
A deck and a cartridge body containing a plurality of staple cavities defined in the deck,
A plurality of staples detachably stored in the staple cavity,
An implantable layer placed on top of the staple cavity.
Structural fibers woven into a top surface, a bottom surface, and a strut wall extending between the top surface and the bottom surface.
A staple cartridge assembly comprising an implantable layer, comprising a reinforcing fiber woven within the strut wall.
(2) The staple cartridge assembly according to embodiment 1, wherein the reinforcing fibers are woven within the top surface and the bottom surface.
(3) The staple cartridge assembly according to embodiment 1, wherein the reinforcing fibers are wound around the structural fibers.
(4) The implantable layer is
A first compression zone with a first density loop between the reinforcing fibers and the structural fibers.
A second compression zone having a second density loop between the reinforcing fibers and the structural fibers, wherein the second density is higher than the first density. 3. The staple cartridge assembly according to embodiment 3.
(5) The cartridge body further comprises a longitudinal slot configured to receive the cutting member, the first compression zone is aligned with the longitudinal slot, and the second compression zone is the staple cavity. The staple cartridge assembly according to embodiment 4, which is aligned with.

(6) The cartridge body includes a proximal end and a distal end, the first compression zone is aligned with the proximal end, and the second compression zone is the first compression zone. The staple cartridge assembly according to embodiment 4, which is located distal to the reference.
(7) The staple cartridge assembly according to embodiment 1, wherein the cartridge body further comprises a longitudinal slot configured to receive a cutting member, the strut wall extending over the entire longitudinal slot.
(8) The staple cartridge assembly according to embodiment 1, wherein each structural fiber comprises a longitudinal seam extending between the proximal and distal ends of the cartridge body.
(9) The staple cartridge assembly of embodiment 8, wherein each of the reinforcing fibers comprises a lateral seam extending through the strut wall.
(10) The staple cartridge assembly according to the first embodiment, wherein the structural fiber is made of a first material, and the reinforcing fiber is made of a second material different from the first material.

(11) The staple cartridge assembly according to embodiment 1, wherein the reinforcing fibers are associated with the structural fibers.
(12) The implantable layer is
A first compression zone with a first density nodule between the reinforcing fiber and the structural fiber.
A second compression zone having a second density nodule between the reinforcing fibers and the structural fibers, wherein the second density is higher than the first density. 11. The staple cartridge assembly according to embodiment 11.
(13) Staple cartridge assembly
A deck and a cartridge body containing a plurality of staple cavities defined in the deck,
A plurality of staples stored in the staple cavity,
An implantable layer placed on top of the staple cavity.
An interconnected structural wall composed of woven fibers and
A staple cartridge assembly comprising an implantable layer, comprising a pocket defined between the structural walls.
(14) The structural wall is
Structural fibers woven into a top surface, a bottom surface, and a strut wall extending between the top surface and the bottom surface.
13. The staple cartridge assembly according to embodiment 13, which is composed of reinforcing fibers woven in the column wall.
(15) The staple cartridge assembly according to embodiment 14, wherein the reinforcing fibers are wound around the structural fibers.

(16) The implantable layer is
A first compression zone with a first density loop between the reinforcing fibers and the structural fibers.
A second compression zone having a second density loop between the reinforcing fibers and the structural fibers, wherein the second density is higher than the first density. 15. The staple cartridge assembly according to embodiment 15.
(17) The cartridge body further comprises a longitudinal slot configured to receive the cutting member, the first compression zone is aligned with the longitudinal slot, and the second compression zone is the staple cavity. 16. The staple cartridge assembly according to embodiment 16, which is aligned with.
(18) The cartridge body comprises a proximal end and a distal end, the first compression zone is aligned with the proximal end, and the second compression zone is the first compression zone. 16. The staple cartridge assembly according to embodiment 16, which is located distal to the.
(19) The staple cartridge assembly according to embodiment 14, wherein the structural fibers are made of a first material, and the reinforcing fibers are made of a second material different from the first material.
(20) The staple cartridge assembly according to embodiment 13, wherein the cartridge body further comprises a longitudinal slot configured to receive a cutting member, the structural wall extending over the entire longitudinal slot.

(21) The staple cartridge assembly according to embodiment 13, wherein the structural wall comprises a longitudinal seam extending between the proximal and distal ends of the cartridge body.
(22) The staple cartridge assembly according to embodiment 21, wherein the structural wall further comprises a lateral seam that extends laterally with respect to the longitudinal seam.
(23) Staple cartridge assembly
A deck and a cartridge body containing a plurality of staple cavities defined in the deck,
A plurality of staples stored in the staple cavity,
An implantable layer placed on top of the staple cavity.
At the top and
At the bottom and
A staple cartridge assembly comprising an implantable layer, comprising a wall woven between said top portion and said bottom portion.

Claims (10)

Staple cartridge assembly
A deck and a cartridge body containing a plurality of staple cavities defined in the deck,
A plurality of staples detachably stored in the staple cavity,
An implantable layer placed on top of the staple cavity.
A wall including a top surface, a bottom surface, and a strut extending between the top surface and the bottom surface.
With an implantable layer, comprising a reinforcing fiber woven within the wall.
A staple cartridge assembly in which the struts are formed of structural fibers and extend between the top surface and the bottom surface to connect the top surface and the bottom surface . The staple cartridge assembly of claim 1, wherein the reinforcing fibers are woven within the top surface and the bottom surface. The staple cartridge assembly of claim 1, wherein the reinforcing fibers are wound around the structural fibers. The staple cartridge assembly of claim 1, wherein the cartridge body further comprises a longitudinal slot configured to receive a cutting member, the wall extending over the entire longitudinal slot. The staple cartridge assembly of claim 1, wherein each structural fiber comprises a longitudinal seam extending between the proximal and distal ends of the cartridge body. The staple cartridge assembly of claim 5, wherein each of the reinforcing fibers comprises a lateral seam extending through the wall. The staple cartridge assembly according to claim 1, wherein the structural fibers are made of a first material, and the reinforcing fibers are made of a second material different from the first material. The staple cartridge assembly of claim 1, wherein the reinforcing fibers are associated with the structural fibers. The embeddable layer is
A first compression zone with a first density nodule between the reinforcing fiber and the structural fiber.
A second compression zone having a second density nodule between the reinforcing fibers and the structural fibers, wherein the second density is higher than the first density. 8. The staple cartridge assembly according to claim 8. Staple cartridge assembly
A deck and a cartridge body containing a plurality of staple cavities defined in the deck,
A plurality of staples stored in the staple cavity,
An implantable layer placed on top of the staple cavity.
At the top and
At the bottom and
A staple cartridge assembly comprising an implantable layer, comprising a wall comprising a strut extending between the top portion and the bottom portion.

Images